[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fUgI9Y3xXeJSqkYGU_yLqXdEYkkd1JfHFQK0yfGeoT4M":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":37,"phaseBuckets":85,"rows":92},"Poznan University of Medical Sciences",[4],143,false,38,2,30636,39,62,[14,17,20,23,26,28,31,34],{"name":15,"count":16},"Hip Osteoarthritis",18,{"name":18,"count":19},"Knee Osteoarthritis",11,{"name":21,"count":22},"Hip Arthropathy",10,{"name":24,"count":25},"Hip Pain Chronic",9,{"name":27,"count":25},"Knee Pain Chronic",{"name":29,"count":30},"Obesity",7,{"name":32,"count":33},"Knee Arthritis",6,{"name":35,"count":36},"Cardiovascular Diseases",5,[38,43,48,53,58,62,66,71,76,80],{"nctId":39,"briefTitle":40,"date":41,"intervention":42},"NCT05426499","Translational PKPD Modeling of Anti-infective Drugs Used in Pediatric Units.","2025-06-30","Patients requiring cefotaxime treatment",{"nctId":44,"briefTitle":45,"date":46,"intervention":47},"NCT07309588","Hyaluronic Acid in the Treatment of Hyposalivation","2025-12-19","Sunecos-200 Injectable Hyaluronic acid and amino acids solution",{"nctId":49,"briefTitle":50,"date":51,"intervention":52},"NCT07449403","SII Levels Following PENG Block in Hip Arthroplasty","2026-05-01","sodium Chloride",{"nctId":54,"briefTitle":55,"date":56,"intervention":57},"NCT07023094","PENG With LFCB vs. ESP Blocks for Pediatric Hip Surgery","2026-05-30","Ropivacaine 0.2% for PENG Block",{"nctId":59,"briefTitle":60,"date":56,"intervention":61},"NCT07061678","The Effect of Dexamethasone Administration Route in Pediatric Brachial Plexus Block","perineural dexamethasone",{"nctId":63,"briefTitle":64,"date":65,"intervention":52},"NCT07449442","SII Levels Following iPACK Block With Adductor Canal Block in Knee Arthroplasty","2026-05-31",{"nctId":67,"briefTitle":68,"date":69,"intervention":70},"NCT06789029","The Effect of Dexamethasone Administration Route and Local Anesthetic Concentration on Pain, Inflammatory Response, and Neuromonitoring in Children Undergoing Scoliosis Correction","2026-07-31","perineural Dexamethasone",{"nctId":72,"briefTitle":73,"date":74,"intervention":75},"NCT07180940","Comparison of Perineural Dexamethasone Versus Dexmedetomidine as Adjuvants to Erector Spinae Plane Block in Lumbar Spine Surgery: A Randomized, Double-blind, Controlled Trial","2026-09-30","0.9%NaCl",{"nctId":77,"briefTitle":78,"date":74,"intervention":79},"NCT07180979","PENG vs L-ESPB With S-ESPB for Analgesia in Total Hip Arthroplasty","Ropivacaine 0.5% Injectable Solution",{"nctId":81,"briefTitle":82,"date":83,"intervention":84},"NCT07327931","PENG Block Variants With Dexamethasone and Dexmedetomidine in Older Adults","2026-12-30","Dexamethasone",[86,87,88,89,90,91],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[93,253,359,420,469,498,520,550,578,596,614,635,653,671,689,707,733,751,773,825,848,893,926,944,962,987,1005,1023,1041,1059,1084,1102,1120,1138,1156,1180,1198,1216,1234,1252,1310,1346,1384,1406,1435,1457,1479,1509,1531,1563,1585,1607,1625,1643,1671,1689,1713,1731,1756,1780,1798,1816,1834,1859,1877,1895,1913,1931,1954,1972,1997,2015,2043,2066,2093,2111,2135,2153,2171,2198,2216,2242,2269,2287,2305,2331,2365,2389,2414,2441,2467,2495,2513,2539,2557,2575,2593,2619,2637],{"intervention":94,"totalTrials":95,"cells":96},"Ropivacaine 0.2% Injectable Solution",14,{"EARLY_PHASE1":97,"PHASE1":100,"PHASE2":102,"PHASE3":104,"PHASE4":106,"NA":183},{"trials":98,"activeCount":99},[],0,{"trials":101,"activeCount":99},[],{"trials":103,"activeCount":99},[],{"trials":105,"activeCount":99},[],{"trials":107,"activeCount":182,"soonestReadout":74},[108,121,132,144,157,166,174],{"nctId":109,"briefTitle":110,"status":111,"phases":112,"primaryCompletion":113,"completion":114,"start":115,"enrollment":116,"conditions":117,"interventions":119},"NCT07023120","PENG Block Optimization: Volume and Dexamethasone Effects","COMPLETED",[90],"2026-02-10","2026-02-20","2025-06-25",120,[21,15,118],"Hip Arthritis",[94,120,94],"Dexamethasone 4mg",{"nctId":122,"briefTitle":123,"status":111,"phases":124,"primaryCompletion":125,"completion":126,"start":127,"enrollment":128,"conditions":129,"interventions":130},"NCT06470139","Dexamethasone for PENG Block in Total Hip Arthroplasty",[90],"2025-01-15","2025-02-10","2024-08-13",60,[15,21,24],[94,131],"Ropivacaine 0.2% Injectable Solution + 4mg Dexamethasone",{"nctId":133,"briefTitle":134,"status":111,"phases":135,"primaryCompletion":136,"completion":137,"start":138,"enrollment":139,"conditions":140,"interventions":142},"NCT06086483","Pain Management After Adductor Canal Block for Total Knee Arthroplasty",[90],"2022-07-20","2023-08-24","2020-06-18",361,[18,32,141,27],"Knee Arthropathy",[94,143],"0.9%sodium chloride",{"nctId":145,"briefTitle":146,"status":147,"phases":148,"primaryCompletion":149,"completion":150,"start":151,"enrollment":128,"conditions":152,"interventions":155},"NCT06302218","ESPB vs iPACK+ACB in Total Knee Arthroplasty","UNKNOWN",[90],"2024-09-30","2025-10-30","2024-04-01",[32,141,18,27,153,154],"Knee Disease","Knee Rheumatism",[94,94,156],"control group",{"nctId":158,"briefTitle":159,"status":111,"phases":160,"primaryCompletion":161,"completion":126,"start":162,"enrollment":128,"conditions":163,"interventions":164},"NCT06304298","NLR and PLR Levels Following IPACK Block in Knee Arthroplasty",[90],"2025-01-16","2024-03-30",[141,18,27],[165,94],"0.9% Sodium Chloride",{"nctId":77,"briefTitle":78,"status":167,"phases":168,"primaryCompletion":74,"completion":169,"start":170,"enrollment":171,"conditions":172,"interventions":173},"RECRUITING",[90],"2026-11-30","2025-09-15",90,[15,21,24],[79,94,94],{"nctId":175,"briefTitle":176,"status":111,"phases":177,"primaryCompletion":178,"completion":178,"start":179,"enrollment":128,"conditions":180,"interventions":181},"NCT07023107","NLR and PLR Levels Following PENG Block in Hip Arthroplasty",[90],"2025-12-09","2025-06-16",[21,15,24],[165,94],1,{"trials":184,"activeCount":33,"soonestReadout":51},[185,197,204,212,220,231,246],{"nctId":186,"briefTitle":187,"status":167,"phases":188,"primaryCompletion":189,"completion":190,"start":191,"enrollment":192,"conditions":193,"interventions":195},"NCT07327372","PENG Block With Dexmedetomidine in Older Adults",[91],"2027-01-31","2027-02-28","2026-02-06",30,[15,194],"Arthropathy of Hip",[94,196],"Dexmedetomidine",{"nctId":49,"briefTitle":50,"status":198,"phases":199,"primaryCompletion":51,"completion":200,"start":201,"enrollment":128,"conditions":202,"interventions":203},"NOT_YET_RECRUITING",[91],"2026-06-30","2026-04-01",[15],[52,94],{"nctId":205,"briefTitle":206,"status":167,"phases":207,"primaryCompletion":208,"completion":189,"start":209,"enrollment":116,"conditions":210,"interventions":211},"NCT07330999","Three Variants of the PENG Block With and Without Perineural Adjuvants in Older Adults",[91],"2027-01-01","2026-02-13",[15],[94,120,196],{"nctId":213,"briefTitle":214,"status":167,"phases":215,"primaryCompletion":208,"completion":189,"start":216,"enrollment":217,"conditions":218,"interventions":219},"NCT07386600","Dexamethasone vs Dexmedetomidine for iPACK + ACB in TKA",[91],"2026-01-01",96,[18],[94,120,196],{"nctId":221,"briefTitle":222,"status":198,"phases":223,"primaryCompletion":224,"completion":225,"start":226,"enrollment":227,"conditions":228,"interventions":230},"NCT07607535","SII Levels Following PENG Block in Pediatric Hip Surgery",[91],"2027-07-31","2027-08-31","2026-06-01",100,[229],"Hip Dysplasia",[94,75],{"nctId":232,"briefTitle":233,"status":147,"phases":234,"primaryCompletion":235,"completion":236,"start":237,"enrollment":238,"conditions":239,"interventions":244},"NCT05944393","Erector Spine Plane (ESP) Block for Analgesia in Pediatric Scoliosis Surgery",[91],"2023-11-30","2023-12-30","2022-09-08",50,[240,241,242,243],"Scoliosis","Regional Anesthesia","Pediatric Anesthesia","Orthopedic Disorder of Spine",[94,245],"Normal saline 0.9% Injectable Solution",{"nctId":247,"briefTitle":248,"status":198,"phases":249,"primaryCompletion":224,"completion":225,"start":226,"enrollment":116,"conditions":250,"interventions":252},"NCT07607509","Lumbar Paravertebral Block vs Erector Spinae Plane Block in Elderly Patients Undergoing Lumbar Spine Surgery",[91],[251],"Spine Disease",[94,94],{"intervention":196,"totalTrials":19,"cells":254},{"EARLY_PHASE1":255,"PHASE1":257,"PHASE2":259,"PHASE3":261,"PHASE4":263,"NA":334},{"trials":256,"activeCount":99},[],{"trials":258,"activeCount":99},[],{"trials":260,"activeCount":99},[],{"trials":262,"activeCount":99},[],{"trials":264,"activeCount":182,"soonestReadout":74},[265,274,286,294,304,312,325],{"nctId":266,"briefTitle":267,"status":147,"phases":268,"primaryCompletion":269,"completion":270,"start":271,"enrollment":192,"conditions":272,"interventions":273},"NCT06233604","Dexamethasone vs. Dexmedetomidine for ESPB in Pain Management After Hip Arthroplasty",[90],"2025-03-30","2025-05-30","2024-04-10",[15,21,24],[143,84,196],{"nctId":275,"briefTitle":276,"status":111,"phases":277,"primaryCompletion":278,"completion":279,"start":280,"enrollment":171,"conditions":281,"interventions":284},"NCT06086431","Dexamethasone Vs. Dexmedetomidine for ESPB in Pain Management After Pediatric Idiopathic Scoliosis Surgery",[90],"2024-09-24","2024-11-05","2023-10-17",[282,283],"Scoliosis Idiopathic","Scoliosis; Adolescence",[285,84,196],"0.9% sodium chloride",{"nctId":72,"briefTitle":73,"status":167,"phases":287,"primaryCompletion":74,"completion":288,"start":289,"enrollment":290,"conditions":291,"interventions":293},[90],"2026-12-31","2025-09-01",150,[251,292],"Spinal Diseases",[75,120,196],{"nctId":295,"briefTitle":296,"status":111,"phases":297,"primaryCompletion":298,"completion":298,"start":299,"enrollment":171,"conditions":300,"interventions":303},"NCT06233565","Dexamethasone vs. Dexmedetomidine for Popliteal Nerve Block in Pain Management After Pediatric Ankle and Foot Surgery",[90],"2025-07-08","2024-02-09",[301,302],"Foot Injuries and Disorders","Ankle Injuries and Disorders",[143,84,196],{"nctId":305,"briefTitle":306,"status":111,"phases":307,"primaryCompletion":308,"completion":309,"start":127,"enrollment":171,"conditions":310,"interventions":311},"NCT06470100","Dexamethasone vs. Dexmedetomidine for ESPB in Pain Management After Knee Arthroplasty",[90],"2026-03-03","2026-03-20",[18,32,153,27],[165,84,196],{"nctId":313,"briefTitle":314,"status":111,"phases":315,"primaryCompletion":316,"completion":317,"start":318,"enrollment":171,"conditions":319,"interventions":323},"NCT06233617","Dexamethasone vs. Dexmedetomidine for ESPB in Pain Management After Spine Surgery",[90],"2025-12-31","2026-01-15","2024-03-01",[320,251,321,322],"Spinal Fusion","Spinal Stenosis","Erector Spinae Plane Block",[165,324,196],"Dexamethasone 4 Mg\u002FmL Injectable Solution",{"nctId":326,"briefTitle":327,"status":111,"phases":328,"primaryCompletion":329,"completion":330,"start":331,"enrollment":128,"conditions":332,"interventions":333},"NCT06789016","Dexmedetomidine for ESPB in Pain Management After Pediatric Idiopathic Scoliosis Surgery",[90],"2026-03-25","2026-03-31","2025-02-01",[282,240,283],[196,75],{"trials":335,"activeCount":358,"soonestReadout":208},[336,340,344,354],{"nctId":186,"briefTitle":187,"status":167,"phases":337,"primaryCompletion":189,"completion":190,"start":191,"enrollment":192,"conditions":338,"interventions":339},[91],[15,194],[94,196],{"nctId":205,"briefTitle":206,"status":167,"phases":341,"primaryCompletion":208,"completion":189,"start":209,"enrollment":116,"conditions":342,"interventions":343},[91],[15],[94,120,196],{"nctId":345,"briefTitle":346,"status":167,"phases":347,"primaryCompletion":208,"completion":189,"start":348,"enrollment":116,"conditions":349,"interventions":352},"NCT07289620","Dexamethasone vs Dexmedetomidine vs Combination as Adjuvants to Popliteal Sciatic Nerve Block in Children",[91],"2026-01-16",[350,351],"Ankle Disease","Foot Diseases",[84,196,353],"Dexamethasone + Dexmedetomidine",{"nctId":213,"briefTitle":214,"status":167,"phases":355,"primaryCompletion":208,"completion":189,"start":216,"enrollment":217,"conditions":356,"interventions":357},[91],[18],[94,120,196],4,{"intervention":120,"totalTrials":30,"cells":360},{"EARLY_PHASE1":361,"PHASE1":363,"PHASE2":365,"PHASE3":367,"PHASE4":369,"NA":398},{"trials":362,"activeCount":99},[],{"trials":364,"activeCount":99},[],{"trials":366,"activeCount":99},[],{"trials":368,"activeCount":99},[],{"trials":370,"activeCount":182,"soonestReadout":74},[371,382,386,390],{"nctId":372,"briefTitle":373,"status":111,"phases":374,"primaryCompletion":375,"completion":329,"start":376,"enrollment":171,"conditions":377,"interventions":380},"NCT07180953","Impact of Dexamethasone Route on Pain and Inflammation in iPACK With ACB for Knee Arthroplasty",[90],"2026-03-01","2025-09-13",[378,27,379],"Osteoarthritis, Knee","Arthropathy of Knee",[381,120,120],"NaCl 0.9%",{"nctId":109,"briefTitle":110,"status":111,"phases":383,"primaryCompletion":113,"completion":114,"start":115,"enrollment":116,"conditions":384,"interventions":385},[90],[21,15,118],[94,120,94],{"nctId":72,"briefTitle":73,"status":167,"phases":387,"primaryCompletion":74,"completion":288,"start":289,"enrollment":290,"conditions":388,"interventions":389},[90],[251,292],[75,120,196],{"nctId":391,"briefTitle":392,"status":111,"phases":393,"primaryCompletion":394,"completion":395,"start":331,"enrollment":128,"conditions":396,"interventions":397},"NCT06789042","Dexamethasone for ESPB in Total Hip Arthroplasty",[90],"2025-07-15","2025-07-18",[15,21,118],[75,120],{"trials":399,"activeCount":419,"soonestReadout":208},[400,411,415],{"nctId":401,"briefTitle":402,"status":198,"phases":403,"primaryCompletion":404,"completion":224,"start":405,"enrollment":406,"conditions":407,"interventions":409},"NCT07581470","Intravenous Dexamethasone (0 vs 4 vs 8 mg) as an Adjunct to PENG Block for Postoperative Analgesia in Total Hip Arthroplasty: A Randomized Double-Blind Trial",[91],"2027-06-30","2026-07-01",198,[408,15],"Osteoarthritis, Hip",[120,410],"Dexamethasone 8mg",{"nctId":205,"briefTitle":206,"status":167,"phases":412,"primaryCompletion":208,"completion":189,"start":209,"enrollment":116,"conditions":413,"interventions":414},[91],[15],[94,120,196],{"nctId":213,"briefTitle":214,"status":167,"phases":416,"primaryCompletion":208,"completion":189,"start":216,"enrollment":217,"conditions":417,"interventions":418},[91],[18],[94,120,196],3,{"intervention":75,"totalTrials":33,"cells":421},{"EARLY_PHASE1":422,"PHASE1":424,"PHASE2":426,"PHASE3":428,"PHASE4":430,"NA":452},{"trials":423,"activeCount":99},[],{"trials":425,"activeCount":99},[],{"trials":427,"activeCount":99},[],{"trials":429,"activeCount":99},[],{"trials":431,"activeCount":182,"soonestReadout":74},[432,440,444,448],{"nctId":433,"briefTitle":434,"status":111,"phases":435,"primaryCompletion":436,"completion":436,"start":437,"enrollment":128,"conditions":438,"interventions":439},"NCT06616220","Dexamethasone for ESPB in Pain Management After Pediatric Idiopathic Scoliosis Surgery",[90],"2025-10-07","2024-10-01",[240,282,283],[84,75],{"nctId":72,"briefTitle":73,"status":167,"phases":441,"primaryCompletion":74,"completion":288,"start":289,"enrollment":290,"conditions":442,"interventions":443},[90],[251,292],[75,120,196],{"nctId":391,"briefTitle":392,"status":111,"phases":445,"primaryCompletion":394,"completion":395,"start":331,"enrollment":128,"conditions":446,"interventions":447},[90],[15,21,118],[75,120],{"nctId":326,"briefTitle":327,"status":111,"phases":449,"primaryCompletion":329,"completion":330,"start":331,"enrollment":128,"conditions":450,"interventions":451},[90],[282,240,283],[196,75],{"trials":453,"activeCount":9,"soonestReadout":208},[454,458],{"nctId":221,"briefTitle":222,"status":198,"phases":455,"primaryCompletion":224,"completion":225,"start":226,"enrollment":227,"conditions":456,"interventions":457},[91],[229],[94,75],{"nctId":459,"briefTitle":460,"status":167,"phases":461,"primaryCompletion":208,"completion":189,"start":462,"enrollment":290,"conditions":463,"interventions":466},"NCT07474909","Perineural vs Intravenous Dexamethasone as an Adjuvant to Brachial Plexus Block in Pediatric Hand Surgery",[91],"2025-12-10",[464,465],"Hand Injuries and Disorders","Wrist Sprain",[467,468,75],"iv dexamethasone","pn dexamethasone",{"intervention":61,"totalTrials":9,"cells":470},{"EARLY_PHASE1":471,"PHASE1":473,"PHASE2":475,"PHASE3":477,"PHASE4":479,"NA":496},{"trials":472,"activeCount":99},[],{"trials":474,"activeCount":99},[],{"trials":476,"activeCount":99},[],{"trials":478,"activeCount":99},[],{"trials":480,"activeCount":9,"soonestReadout":56},[481,490],{"nctId":59,"briefTitle":60,"status":167,"phases":482,"primaryCompletion":56,"completion":483,"start":484,"enrollment":171,"conditions":485,"interventions":487},[90],"2026-06-28","2025-10-01",[486],"Arm",[61,488,489],"intravenous dexamethasone","0.2ml\u002Fkg 0.2% ropivacaine",{"nctId":67,"briefTitle":68,"status":167,"phases":491,"primaryCompletion":69,"completion":74,"start":331,"enrollment":128,"conditions":492,"interventions":494},[90],[493],"Scoliosis Idiopathic Adolescent",[70,495],"intravenous Dexamethasone",{"trials":497,"activeCount":99},[],{"intervention":488,"totalTrials":9,"cells":499},{"EARLY_PHASE1":500,"PHASE1":502,"PHASE2":504,"PHASE3":506,"PHASE4":508,"NA":518},{"trials":501,"activeCount":99},[],{"trials":503,"activeCount":99},[],{"trials":505,"activeCount":99},[],{"trials":507,"activeCount":99},[],{"trials":509,"activeCount":9,"soonestReadout":56},[510,514],{"nctId":59,"briefTitle":60,"status":167,"phases":511,"primaryCompletion":56,"completion":483,"start":484,"enrollment":171,"conditions":512,"interventions":513},[90],[486],[61,488,489],{"nctId":67,"briefTitle":68,"status":167,"phases":515,"primaryCompletion":69,"completion":74,"start":331,"enrollment":128,"conditions":516,"interventions":517},[90],[493],[70,495],{"trials":519,"activeCount":99},[],{"intervention":79,"totalTrials":9,"cells":521},{"EARLY_PHASE1":522,"PHASE1":524,"PHASE2":526,"PHASE3":528,"PHASE4":530,"NA":548},{"trials":523,"activeCount":99},[],{"trials":525,"activeCount":99},[],{"trials":527,"activeCount":99},[],{"trials":529,"activeCount":99},[],{"trials":531,"activeCount":182,"soonestReadout":74},[532,544],{"nctId":533,"briefTitle":534,"status":111,"phases":535,"primaryCompletion":536,"completion":537,"start":538,"enrollment":539,"conditions":540,"interventions":542},"NCT05944380","PENG Block for Total Hip Arthroplasty",[90],"2022-06-23","2023-01-30","2020-06-16",556,[15,21,541,24],"Hip Disease",[79,543],"0,9% normal saline",{"nctId":77,"briefTitle":78,"status":167,"phases":545,"primaryCompletion":74,"completion":169,"start":170,"enrollment":171,"conditions":546,"interventions":547},[90],[15,21,24],[79,94,94],{"trials":549,"activeCount":99},[],{"intervention":551,"totalTrials":182,"cells":552},"Fluoxetine",{"EARLY_PHASE1":553,"PHASE1":555,"PHASE2":557,"PHASE3":559,"PHASE4":561,"NA":576},{"trials":554,"activeCount":99},[],{"trials":556,"activeCount":99},[],{"trials":558,"activeCount":99},[],{"trials":560,"activeCount":99},[],{"trials":562,"activeCount":182,"soonestReadout":567},[563],{"nctId":564,"briefTitle":565,"status":167,"phases":566,"primaryCompletion":567,"completion":567,"start":568,"enrollment":569,"conditions":570,"interventions":573},"NCT07478796","TDM-Guided Treatment With SSRIs in Hospitalized Adults and Children",[90],"2027-11-30","2025-04-03",180,[571,572],"Depression - Major Depressive Disorder","Depressive Episodes",[551,574,575],"Escitalopram","Sertralin",{"trials":577,"activeCount":99},[],{"intervention":574,"totalTrials":182,"cells":579},{"EARLY_PHASE1":580,"PHASE1":582,"PHASE2":584,"PHASE3":586,"PHASE4":588,"NA":594},{"trials":581,"activeCount":99},[],{"trials":583,"activeCount":99},[],{"trials":585,"activeCount":99},[],{"trials":587,"activeCount":99},[],{"trials":589,"activeCount":182,"soonestReadout":567},[590],{"nctId":564,"briefTitle":565,"status":167,"phases":591,"primaryCompletion":567,"completion":567,"start":568,"enrollment":569,"conditions":592,"interventions":593},[90],[571,572],[551,574,575],{"trials":595,"activeCount":99},[],{"intervention":575,"totalTrials":182,"cells":597},{"EARLY_PHASE1":598,"PHASE1":600,"PHASE2":602,"PHASE3":604,"PHASE4":606,"NA":612},{"trials":599,"activeCount":99},[],{"trials":601,"activeCount":99},[],{"trials":603,"activeCount":99},[],{"trials":605,"activeCount":99},[],{"trials":607,"activeCount":182,"soonestReadout":567},[608],{"nctId":564,"briefTitle":565,"status":167,"phases":609,"primaryCompletion":567,"completion":567,"start":568,"enrollment":569,"conditions":610,"interventions":611},[90],[571,572],[551,574,575],{"trials":613,"activeCount":99},[],{"intervention":57,"totalTrials":182,"cells":615},{"EARLY_PHASE1":616,"PHASE1":618,"PHASE2":620,"PHASE3":622,"PHASE4":624,"NA":633},{"trials":617,"activeCount":99},[],{"trials":619,"activeCount":99},[],{"trials":621,"activeCount":99},[],{"trials":623,"activeCount":99},[],{"trials":625,"activeCount":182,"soonestReadout":56},[626],{"nctId":54,"briefTitle":55,"status":167,"phases":627,"primaryCompletion":56,"completion":200,"start":179,"enrollment":128,"conditions":628,"interventions":629},[90],[541,229,21],[57,630,631,632],"Ropivacaine 0.2% for LFCB","Ropivacaine 0.2% for L-ESPB","Ropivacaine 0.2% for S-ESPB",{"trials":634,"activeCount":99},[],{"intervention":630,"totalTrials":182,"cells":636},{"EARLY_PHASE1":637,"PHASE1":639,"PHASE2":641,"PHASE3":643,"PHASE4":645,"NA":651},{"trials":638,"activeCount":99},[],{"trials":640,"activeCount":99},[],{"trials":642,"activeCount":99},[],{"trials":644,"activeCount":99},[],{"trials":646,"activeCount":182,"soonestReadout":56},[647],{"nctId":54,"briefTitle":55,"status":167,"phases":648,"primaryCompletion":56,"completion":200,"start":179,"enrollment":128,"conditions":649,"interventions":650},[90],[541,229,21],[57,630,631,632],{"trials":652,"activeCount":99},[],{"intervention":631,"totalTrials":182,"cells":654},{"EARLY_PHASE1":655,"PHASE1":657,"PHASE2":659,"PHASE3":661,"PHASE4":663,"NA":669},{"trials":656,"activeCount":99},[],{"trials":658,"activeCount":99},[],{"trials":660,"activeCount":99},[],{"trials":662,"activeCount":99},[],{"trials":664,"activeCount":182,"soonestReadout":56},[665],{"nctId":54,"briefTitle":55,"status":167,"phases":666,"primaryCompletion":56,"completion":200,"start":179,"enrollment":128,"conditions":667,"interventions":668},[90],[541,229,21],[57,630,631,632],{"trials":670,"activeCount":99},[],{"intervention":632,"totalTrials":182,"cells":672},{"EARLY_PHASE1":673,"PHASE1":675,"PHASE2":677,"PHASE3":679,"PHASE4":681,"NA":687},{"trials":674,"activeCount":99},[],{"trials":676,"activeCount":99},[],{"trials":678,"activeCount":99},[],{"trials":680,"activeCount":99},[],{"trials":682,"activeCount":182,"soonestReadout":56},[683],{"nctId":54,"briefTitle":55,"status":167,"phases":684,"primaryCompletion":56,"completion":200,"start":179,"enrollment":128,"conditions":685,"interventions":686},[90],[541,229,21],[57,630,631,632],{"trials":688,"activeCount":99},[],{"intervention":489,"totalTrials":182,"cells":690},{"EARLY_PHASE1":691,"PHASE1":693,"PHASE2":695,"PHASE3":697,"PHASE4":699,"NA":705},{"trials":692,"activeCount":99},[],{"trials":694,"activeCount":99},[],{"trials":696,"activeCount":99},[],{"trials":698,"activeCount":99},[],{"trials":700,"activeCount":182,"soonestReadout":56},[701],{"nctId":59,"briefTitle":60,"status":167,"phases":702,"primaryCompletion":56,"completion":483,"start":484,"enrollment":171,"conditions":703,"interventions":704},[90],[486],[61,488,489],{"trials":706,"activeCount":99},[],{"intervention":708,"totalTrials":182,"cells":709},"Allopurinol 200 mg",{"EARLY_PHASE1":710,"PHASE1":712,"PHASE2":714,"PHASE3":716,"PHASE4":729,"NA":731},{"trials":711,"activeCount":99},[],{"trials":713,"activeCount":99},[],{"trials":715,"activeCount":99},[],{"trials":717,"activeCount":182,"soonestReadout":722},[718],{"nctId":719,"briefTitle":720,"status":167,"phases":721,"primaryCompletion":722,"completion":722,"start":723,"enrollment":724,"conditions":725,"interventions":727},"NCT05943821","The Effect of Allopurinol on the Risk of Cardiovascular Events in Patients with Cardiovascular Risk",[89],"2028-07-31","2023-09-01",1116,[35,726],"Uric Acid",[708,728],"Optional intervention",{"trials":730,"activeCount":99},[],{"trials":732,"activeCount":99},[],{"intervention":728,"totalTrials":182,"cells":734},{"EARLY_PHASE1":735,"PHASE1":737,"PHASE2":739,"PHASE3":741,"PHASE4":747,"NA":749},{"trials":736,"activeCount":99},[],{"trials":738,"activeCount":99},[],{"trials":740,"activeCount":99},[],{"trials":742,"activeCount":182,"soonestReadout":722},[743],{"nctId":719,"briefTitle":720,"status":167,"phases":744,"primaryCompletion":722,"completion":722,"start":723,"enrollment":724,"conditions":745,"interventions":746},[89],[35,726],[708,728],{"trials":748,"activeCount":99},[],{"trials":750,"activeCount":99},[],{"intervention":47,"totalTrials":182,"cells":752},{"EARLY_PHASE1":753,"PHASE1":755,"PHASE2":757,"PHASE3":767,"PHASE4":769,"NA":771},{"trials":754,"activeCount":99},[],{"trials":756,"activeCount":99},[],{"trials":758,"activeCount":182,"soonestReadout":46},[759],{"nctId":44,"briefTitle":45,"status":760,"phases":761,"primaryCompletion":46,"completion":762,"start":763,"enrollment":227,"conditions":764,"interventions":766},"ENROLLING_BY_INVITATION",[87,88],"2026-01-19","2025-07-01",[765],"Xerostomia Due to Hyposecretion of Salivary Gland",[47],{"trials":768,"activeCount":99},[],{"trials":770,"activeCount":99},[],{"trials":772,"activeCount":99},[],{"intervention":84,"totalTrials":774,"cells":775},8,{"EARLY_PHASE1":776,"PHASE1":778,"PHASE2":780,"PHASE3":782,"PHASE4":784,"NA":806},{"trials":777,"activeCount":99},[],{"trials":779,"activeCount":99},[],{"trials":781,"activeCount":99},[],{"trials":783,"activeCount":99},[],{"trials":785,"activeCount":99},[786,790,794,798,802],{"nctId":266,"briefTitle":267,"status":147,"phases":787,"primaryCompletion":269,"completion":270,"start":271,"enrollment":192,"conditions":788,"interventions":789},[90],[15,21,24],[143,84,196],{"nctId":433,"briefTitle":434,"status":111,"phases":791,"primaryCompletion":436,"completion":436,"start":437,"enrollment":128,"conditions":792,"interventions":793},[90],[240,282,283],[84,75],{"nctId":275,"briefTitle":276,"status":111,"phases":795,"primaryCompletion":278,"completion":279,"start":280,"enrollment":171,"conditions":796,"interventions":797},[90],[282,283],[285,84,196],{"nctId":295,"briefTitle":296,"status":111,"phases":799,"primaryCompletion":298,"completion":298,"start":299,"enrollment":171,"conditions":800,"interventions":801},[90],[301,302],[143,84,196],{"nctId":305,"briefTitle":306,"status":111,"phases":803,"primaryCompletion":308,"completion":309,"start":127,"enrollment":171,"conditions":804,"interventions":805},[90],[18,32,153,27],[165,84,196],{"trials":807,"activeCount":419,"soonestReadout":83},[808,817,821],{"nctId":809,"briefTitle":810,"status":198,"phases":811,"primaryCompletion":812,"completion":813,"start":226,"enrollment":171,"conditions":814,"interventions":815},"NCT07584200","Comparison of Spinal Anesthesia With Intrathecal Morphine Versus PENG Block With or Without Dexamethasone in Hip Arthroplasty",[91],"2027-03-31","2027-05-01",[194,15],[816,84],"Intrathecal Morphine",{"nctId":345,"briefTitle":346,"status":167,"phases":818,"primaryCompletion":208,"completion":189,"start":348,"enrollment":116,"conditions":819,"interventions":820},[91],[350,351],[84,196,353],{"nctId":81,"briefTitle":82,"status":167,"phases":822,"primaryCompletion":83,"completion":189,"start":209,"enrollment":116,"conditions":823,"interventions":824},[91],[15,24],[84,84,84],{"intervention":52,"totalTrials":9,"cells":826},{"EARLY_PHASE1":827,"PHASE1":829,"PHASE2":831,"PHASE3":833,"PHASE4":835,"NA":837},{"trials":828,"activeCount":99},[],{"trials":830,"activeCount":99},[],{"trials":832,"activeCount":99},[],{"trials":834,"activeCount":99},[],{"trials":836,"activeCount":99},[],{"trials":838,"activeCount":9,"soonestReadout":51},[839,843],{"nctId":49,"briefTitle":50,"status":198,"phases":840,"primaryCompletion":51,"completion":200,"start":201,"enrollment":128,"conditions":841,"interventions":842},[91],[15],[52,94],{"nctId":63,"briefTitle":64,"status":167,"phases":844,"primaryCompletion":65,"completion":200,"start":375,"enrollment":128,"conditions":845,"interventions":846},[91],[18],[52,847],"Ropivacaine Hydrocloride",{"intervention":849,"totalTrials":419,"cells":850},"Sodium Chloride 0.9% Inj",{"EARLY_PHASE1":851,"PHASE1":853,"PHASE2":855,"PHASE3":857,"PHASE4":859,"NA":882},{"trials":852,"activeCount":99},[],{"trials":854,"activeCount":99},[],{"trials":856,"activeCount":99},[],{"trials":858,"activeCount":99},[],{"trials":860,"activeCount":99},[861,872],{"nctId":862,"briefTitle":863,"status":111,"phases":864,"primaryCompletion":41,"completion":865,"start":280,"enrollment":171,"conditions":866,"interventions":869},"NCT05887765","Effect of Systematic Dexamethasone on the Duration of Popliteal Nerve Block for Anesthesia After Pediatric Ankle Surgery",[90],"2025-07-29",[350,867,351,868],"Foot Deformities","Cerebral Palsy",[849,870,871],"0,1mg\u002Fkg Dexamethasone","0,2mg\u002Fkg Dexamethasone",{"nctId":873,"briefTitle":874,"status":111,"phases":875,"primaryCompletion":876,"completion":877,"start":878,"enrollment":171,"conditions":879,"interventions":881},"NCT05887778","Dexamethasone in Supraclavicular Brachial Plexus Block for Anesthesia After Pediatric Hand\u002FWrist Surgery",[90],"2026-03-30","2026-04-10","2023-09-18",[880,464],"Wrist Disease",[849,870,871],{"trials":883,"activeCount":182,"soonestReadout":888},[884],{"nctId":885,"briefTitle":886,"status":198,"phases":887,"primaryCompletion":888,"completion":404,"start":226,"enrollment":171,"conditions":889,"interventions":890},"NCT07581457","Tranexamic Acid in Pediatric Idiopathic Scoliosis Surgery",[91],"2027-05-31",[282,283],[891,849,892],"Tranexamic Acid Bolus Plus","Tranexamic Acid Bolus Only",{"intervention":894,"totalTrials":9,"cells":895},"0.2% ropivacaine",{"EARLY_PHASE1":896,"PHASE1":898,"PHASE2":900,"PHASE3":902,"PHASE4":904,"NA":917},{"trials":897,"activeCount":99},[],{"trials":899,"activeCount":99},[],{"trials":901,"activeCount":99},[],{"trials":903,"activeCount":99},[],{"trials":905,"activeCount":99},[906],{"nctId":907,"briefTitle":908,"status":111,"phases":909,"primaryCompletion":910,"completion":911,"start":912,"enrollment":128,"conditions":913,"interventions":916},"NCT06393530","Erector Spinae Plane Block for Cervical Spine Surgery",[90],"2025-12-30","2026-01-17","2024-07-15",[914,251,915],"Spine Fusion","Spinal Disease",[143,894],{"trials":918,"activeCount":182,"soonestReadout":813},[919],{"nctId":920,"briefTitle":921,"status":167,"phases":922,"primaryCompletion":813,"completion":404,"start":375,"enrollment":569,"conditions":923,"interventions":924},"NCT07449468","PENG Block and Delirium After Hip Arthroplasty",[91],[15],[925,894],"sham block with 0.9% sodium chloride",{"intervention":891,"totalTrials":182,"cells":927},{"EARLY_PHASE1":928,"PHASE1":930,"PHASE2":932,"PHASE3":934,"PHASE4":936,"NA":938},{"trials":929,"activeCount":99},[],{"trials":931,"activeCount":99},[],{"trials":933,"activeCount":99},[],{"trials":935,"activeCount":99},[],{"trials":937,"activeCount":99},[],{"trials":939,"activeCount":182,"soonestReadout":888},[940],{"nctId":885,"briefTitle":886,"status":198,"phases":941,"primaryCompletion":888,"completion":404,"start":226,"enrollment":171,"conditions":942,"interventions":943},[91],[282,283],[891,849,892],{"intervention":892,"totalTrials":182,"cells":945},{"EARLY_PHASE1":946,"PHASE1":948,"PHASE2":950,"PHASE3":952,"PHASE4":954,"NA":956},{"trials":947,"activeCount":99},[],{"trials":949,"activeCount":99},[],{"trials":951,"activeCount":99},[],{"trials":953,"activeCount":99},[],{"trials":955,"activeCount":99},[],{"trials":957,"activeCount":182,"soonestReadout":888},[958],{"nctId":885,"briefTitle":886,"status":198,"phases":959,"primaryCompletion":888,"completion":404,"start":226,"enrollment":171,"conditions":960,"interventions":961},[91],[282,283],[891,849,892],{"intervention":963,"totalTrials":182,"cells":964},"chemotherapy according to Stupp protocol",{"EARLY_PHASE1":965,"PHASE1":967,"PHASE2":969,"PHASE3":971,"PHASE4":973,"NA":975},{"trials":966,"activeCount":99},[],{"trials":968,"activeCount":99},[],{"trials":970,"activeCount":99},[],{"trials":972,"activeCount":99},[],{"trials":974,"activeCount":99},[],{"trials":976,"activeCount":182,"soonestReadout":981},[977],{"nctId":978,"briefTitle":979,"status":167,"phases":980,"primaryCompletion":981,"completion":982,"start":983,"enrollment":227,"conditions":984,"interventions":986},"NCT06271421","NanoTherm In Adjuvant Therapy of Glioblastoma Multiforme",[91],"2027-02-01","2027-09-01","2024-01-01",[985],"Glioblastoma Multiforme",[963],{"intervention":410,"totalTrials":182,"cells":988},{"EARLY_PHASE1":989,"PHASE1":991,"PHASE2":993,"PHASE3":995,"PHASE4":997,"NA":999},{"trials":990,"activeCount":99},[],{"trials":992,"activeCount":99},[],{"trials":994,"activeCount":99},[],{"trials":996,"activeCount":99},[],{"trials":998,"activeCount":99},[],{"trials":1000,"activeCount":182,"soonestReadout":404},[1001],{"nctId":401,"briefTitle":402,"status":198,"phases":1002,"primaryCompletion":404,"completion":224,"start":405,"enrollment":406,"conditions":1003,"interventions":1004},[91],[408,15],[120,410],{"intervention":925,"totalTrials":182,"cells":1006},{"EARLY_PHASE1":1007,"PHASE1":1009,"PHASE2":1011,"PHASE3":1013,"PHASE4":1015,"NA":1017},{"trials":1008,"activeCount":99},[],{"trials":1010,"activeCount":99},[],{"trials":1012,"activeCount":99},[],{"trials":1014,"activeCount":99},[],{"trials":1016,"activeCount":99},[],{"trials":1018,"activeCount":182,"soonestReadout":813},[1019],{"nctId":920,"briefTitle":921,"status":167,"phases":1020,"primaryCompletion":813,"completion":404,"start":375,"enrollment":569,"conditions":1021,"interventions":1022},[91],[15],[925,894],{"intervention":816,"totalTrials":182,"cells":1024},{"EARLY_PHASE1":1025,"PHASE1":1027,"PHASE2":1029,"PHASE3":1031,"PHASE4":1033,"NA":1035},{"trials":1026,"activeCount":99},[],{"trials":1028,"activeCount":99},[],{"trials":1030,"activeCount":99},[],{"trials":1032,"activeCount":99},[],{"trials":1034,"activeCount":99},[],{"trials":1036,"activeCount":182,"soonestReadout":812},[1037],{"nctId":809,"briefTitle":810,"status":198,"phases":1038,"primaryCompletion":812,"completion":813,"start":226,"enrollment":171,"conditions":1039,"interventions":1040},[91],[194,15],[816,84],{"intervention":353,"totalTrials":182,"cells":1042},{"EARLY_PHASE1":1043,"PHASE1":1045,"PHASE2":1047,"PHASE3":1049,"PHASE4":1051,"NA":1053},{"trials":1044,"activeCount":99},[],{"trials":1046,"activeCount":99},[],{"trials":1048,"activeCount":99},[],{"trials":1050,"activeCount":99},[],{"trials":1052,"activeCount":99},[],{"trials":1054,"activeCount":182,"soonestReadout":208},[1055],{"nctId":345,"briefTitle":346,"status":167,"phases":1056,"primaryCompletion":208,"completion":189,"start":348,"enrollment":116,"conditions":1057,"interventions":1058},[91],[350,351],[84,196,353],{"intervention":42,"totalTrials":182,"cells":1060},{"EARLY_PHASE1":1061,"PHASE1":1063,"PHASE2":1065,"PHASE3":1067,"PHASE4":1069,"NA":1071},{"trials":1062,"activeCount":99},[],{"trials":1064,"activeCount":99},[],{"trials":1066,"activeCount":99},[],{"trials":1068,"activeCount":99},[],{"trials":1070,"activeCount":99},[],{"trials":1072,"activeCount":182,"soonestReadout":41},[1073],{"nctId":39,"briefTitle":40,"status":167,"phases":1074,"primaryCompletion":41,"completion":1075,"start":1076,"enrollment":290,"conditions":1077,"interventions":1079},[],"2025-09-30","2021-10-01",[1078],"Population Modeling of Anti-infective Drugs",[42,1080,1081,1082,1083],"Patients requiring meropenem treatment","Patients requiring fluconazole treatment","Patients requiring isavuconazole treatment","Patients requiring anidulafungin treatment",{"intervention":1080,"totalTrials":182,"cells":1085},{"EARLY_PHASE1":1086,"PHASE1":1088,"PHASE2":1090,"PHASE3":1092,"PHASE4":1094,"NA":1096},{"trials":1087,"activeCount":99},[],{"trials":1089,"activeCount":99},[],{"trials":1091,"activeCount":99},[],{"trials":1093,"activeCount":99},[],{"trials":1095,"activeCount":99},[],{"trials":1097,"activeCount":182,"soonestReadout":41},[1098],{"nctId":39,"briefTitle":40,"status":167,"phases":1099,"primaryCompletion":41,"completion":1075,"start":1076,"enrollment":290,"conditions":1100,"interventions":1101},[],[1078],[42,1080,1081,1082,1083],{"intervention":1081,"totalTrials":182,"cells":1103},{"EARLY_PHASE1":1104,"PHASE1":1106,"PHASE2":1108,"PHASE3":1110,"PHASE4":1112,"NA":1114},{"trials":1105,"activeCount":99},[],{"trials":1107,"activeCount":99},[],{"trials":1109,"activeCount":99},[],{"trials":1111,"activeCount":99},[],{"trials":1113,"activeCount":99},[],{"trials":1115,"activeCount":182,"soonestReadout":41},[1116],{"nctId":39,"briefTitle":40,"status":167,"phases":1117,"primaryCompletion":41,"completion":1075,"start":1076,"enrollment":290,"conditions":1118,"interventions":1119},[],[1078],[42,1080,1081,1082,1083],{"intervention":1082,"totalTrials":182,"cells":1121},{"EARLY_PHASE1":1122,"PHASE1":1124,"PHASE2":1126,"PHASE3":1128,"PHASE4":1130,"NA":1132},{"trials":1123,"activeCount":99},[],{"trials":1125,"activeCount":99},[],{"trials":1127,"activeCount":99},[],{"trials":1129,"activeCount":99},[],{"trials":1131,"activeCount":99},[],{"trials":1133,"activeCount":182,"soonestReadout":41},[1134],{"nctId":39,"briefTitle":40,"status":167,"phases":1135,"primaryCompletion":41,"completion":1075,"start":1076,"enrollment":290,"conditions":1136,"interventions":1137},[],[1078],[42,1080,1081,1082,1083],{"intervention":1083,"totalTrials":182,"cells":1139},{"EARLY_PHASE1":1140,"PHASE1":1142,"PHASE2":1144,"PHASE3":1146,"PHASE4":1148,"NA":1150},{"trials":1141,"activeCount":99},[],{"trials":1143,"activeCount":99},[],{"trials":1145,"activeCount":99},[],{"trials":1147,"activeCount":99},[],{"trials":1149,"activeCount":99},[],{"trials":1151,"activeCount":182,"soonestReadout":41},[1152],{"nctId":39,"briefTitle":40,"status":167,"phases":1153,"primaryCompletion":41,"completion":1075,"start":1076,"enrollment":290,"conditions":1154,"interventions":1155},[],[1078],[42,1080,1081,1082,1083],{"intervention":1157,"totalTrials":182,"cells":1158},"Ropivacaine 0.2% for Interscalene Block",{"EARLY_PHASE1":1159,"PHASE1":1161,"PHASE2":1163,"PHASE3":1165,"PHASE4":1167,"NA":1169},{"trials":1160,"activeCount":99},[],{"trials":1162,"activeCount":99},[],{"trials":1164,"activeCount":99},[],{"trials":1166,"activeCount":99},[],{"trials":1168,"activeCount":99},[],{"trials":1170,"activeCount":182,"soonestReadout":208},[1171],{"nctId":1172,"briefTitle":1173,"status":167,"phases":1174,"primaryCompletion":208,"completion":189,"start":462,"enrollment":1175,"conditions":1176,"interventions":1178},"NCT07474896","Diaphragm-Sparing Regional Anesthesia Techniques for Shoulder Surgery",[91],70,[1177],"Osteoarthritis Shoulder",[1157,1179],"Ropivacaine 0.2% for Infraclavicular and Suprascapular Nerve Blocks",{"intervention":1179,"totalTrials":182,"cells":1181},{"EARLY_PHASE1":1182,"PHASE1":1184,"PHASE2":1186,"PHASE3":1188,"PHASE4":1190,"NA":1192},{"trials":1183,"activeCount":99},[],{"trials":1185,"activeCount":99},[],{"trials":1187,"activeCount":99},[],{"trials":1189,"activeCount":99},[],{"trials":1191,"activeCount":99},[],{"trials":1193,"activeCount":182,"soonestReadout":208},[1194],{"nctId":1172,"briefTitle":1173,"status":167,"phases":1195,"primaryCompletion":208,"completion":189,"start":462,"enrollment":1175,"conditions":1196,"interventions":1197},[91],[1177],[1157,1179],{"intervention":847,"totalTrials":182,"cells":1199},{"EARLY_PHASE1":1200,"PHASE1":1202,"PHASE2":1204,"PHASE3":1206,"PHASE4":1208,"NA":1210},{"trials":1201,"activeCount":99},[],{"trials":1203,"activeCount":99},[],{"trials":1205,"activeCount":99},[],{"trials":1207,"activeCount":99},[],{"trials":1209,"activeCount":99},[],{"trials":1211,"activeCount":182,"soonestReadout":65},[1212],{"nctId":63,"briefTitle":64,"status":167,"phases":1213,"primaryCompletion":65,"completion":200,"start":375,"enrollment":128,"conditions":1214,"interventions":1215},[91],[18],[52,847],{"intervention":467,"totalTrials":182,"cells":1217},{"EARLY_PHASE1":1218,"PHASE1":1220,"PHASE2":1222,"PHASE3":1224,"PHASE4":1226,"NA":1228},{"trials":1219,"activeCount":99},[],{"trials":1221,"activeCount":99},[],{"trials":1223,"activeCount":99},[],{"trials":1225,"activeCount":99},[],{"trials":1227,"activeCount":99},[],{"trials":1229,"activeCount":182,"soonestReadout":208},[1230],{"nctId":459,"briefTitle":460,"status":167,"phases":1231,"primaryCompletion":208,"completion":189,"start":462,"enrollment":290,"conditions":1232,"interventions":1233},[91],[464,465],[467,468,75],{"intervention":468,"totalTrials":182,"cells":1235},{"EARLY_PHASE1":1236,"PHASE1":1238,"PHASE2":1240,"PHASE3":1242,"PHASE4":1244,"NA":1246},{"trials":1237,"activeCount":99},[],{"trials":1239,"activeCount":99},[],{"trials":1241,"activeCount":99},[],{"trials":1243,"activeCount":99},[],{"trials":1245,"activeCount":99},[],{"trials":1247,"activeCount":182,"soonestReadout":208},[1248],{"nctId":459,"briefTitle":460,"status":167,"phases":1249,"primaryCompletion":208,"completion":189,"start":462,"enrollment":290,"conditions":1250,"interventions":1251},[91],[464,465],[467,468,75],{"intervention":165,"totalTrials":30,"cells":1253},{"EARLY_PHASE1":1254,"PHASE1":1256,"PHASE2":1258,"PHASE3":1260,"PHASE4":1262,"NA":1308},{"trials":1255,"activeCount":99},[],{"trials":1257,"activeCount":99},[],{"trials":1259,"activeCount":99},[],{"trials":1261,"activeCount":99},[],{"trials":1263,"activeCount":99},[1264,1277,1288,1292,1296,1300,1304],{"nctId":1265,"briefTitle":1266,"status":147,"phases":1267,"primaryCompletion":1268,"completion":1269,"start":1270,"enrollment":171,"conditions":1271,"interventions":1273},"NCT06304324","Dexmedetomidine Vs Dexamethasone in Popliteal Nerve Block",[90],"2025-03-31","2025-04-30","2024-05-06",[350,302,1272,351],"Foot Injury",[1274,1275,1276],"0.9% Sodium chloride","0.1mg\u002Fkg Dexamethasone","0.05ug\u002Fkg Dexmedetomidine",{"nctId":1278,"briefTitle":1279,"status":111,"phases":1280,"primaryCompletion":1281,"completion":1282,"start":280,"enrollment":227,"conditions":1283,"interventions":1286},"NCT06087601","The Impact of Genicular Nerves Chemical Neurolysis on the Quality of Life of Patients with Advanced Knee Osteoarthritis.",[90],"2025-01-10","2025-01-14",[1284,1285],"Osteo Arthritis Knee","Osteoarthritis",[1274,1287],"95% ethanol",{"nctId":275,"briefTitle":276,"status":111,"phases":1289,"primaryCompletion":278,"completion":279,"start":280,"enrollment":171,"conditions":1290,"interventions":1291},[90],[282,283],[285,84,196],{"nctId":158,"briefTitle":159,"status":111,"phases":1293,"primaryCompletion":161,"completion":126,"start":162,"enrollment":128,"conditions":1294,"interventions":1295},[90],[141,18,27],[165,94],{"nctId":305,"briefTitle":306,"status":111,"phases":1297,"primaryCompletion":308,"completion":309,"start":127,"enrollment":171,"conditions":1298,"interventions":1299},[90],[18,32,153,27],[165,84,196],{"nctId":313,"briefTitle":314,"status":111,"phases":1301,"primaryCompletion":316,"completion":317,"start":318,"enrollment":171,"conditions":1302,"interventions":1303},[90],[320,251,321,322],[165,324,196],{"nctId":175,"briefTitle":176,"status":111,"phases":1305,"primaryCompletion":178,"completion":178,"start":179,"enrollment":128,"conditions":1306,"interventions":1307},[90],[21,15,24],[165,94],{"trials":1309,"activeCount":99},[],{"intervention":143,"totalTrials":36,"cells":1311},{"EARLY_PHASE1":1312,"PHASE1":1314,"PHASE2":1316,"PHASE3":1318,"PHASE4":1320,"NA":1344},{"trials":1313,"activeCount":99},[],{"trials":1315,"activeCount":99},[],{"trials":1317,"activeCount":99},[],{"trials":1319,"activeCount":99},[],{"trials":1321,"activeCount":99},[1322,1326,1330,1336,1340],{"nctId":266,"briefTitle":267,"status":147,"phases":1323,"primaryCompletion":269,"completion":270,"start":271,"enrollment":192,"conditions":1324,"interventions":1325},[90],[15,21,24],[143,84,196],{"nctId":133,"briefTitle":134,"status":111,"phases":1327,"primaryCompletion":136,"completion":137,"start":138,"enrollment":139,"conditions":1328,"interventions":1329},[90],[18,32,141,27],[94,143],{"nctId":1331,"briefTitle":1332,"status":111,"phases":1333,"primaryCompletion":1281,"completion":1282,"start":280,"enrollment":227,"conditions":1334,"interventions":1335},"NCT06087588","Pericapsular Nerve Group Block Chemical Neurolysis in Advanced Hip Osteoarthritis",[90],[1285,408],[143,1287],{"nctId":295,"briefTitle":296,"status":111,"phases":1337,"primaryCompletion":298,"completion":298,"start":299,"enrollment":171,"conditions":1338,"interventions":1339},[90],[301,302],[143,84,196],{"nctId":907,"briefTitle":908,"status":111,"phases":1341,"primaryCompletion":910,"completion":911,"start":912,"enrollment":128,"conditions":1342,"interventions":1343},[90],[914,251,915],[143,894],{"trials":1345,"activeCount":99},[],{"intervention":1275,"totalTrials":419,"cells":1347},{"EARLY_PHASE1":1348,"PHASE1":1350,"PHASE2":1352,"PHASE3":1354,"PHASE4":1356,"NA":1382},{"trials":1349,"activeCount":99},[],{"trials":1351,"activeCount":99},[],{"trials":1353,"activeCount":99},[],{"trials":1355,"activeCount":99},[],{"trials":1357,"activeCount":99},[1358,1362,1373],{"nctId":1265,"briefTitle":1266,"status":147,"phases":1359,"primaryCompletion":1268,"completion":1269,"start":1270,"enrollment":171,"conditions":1360,"interventions":1361},[90],[350,302,1272,351],[1274,1275,1276],{"nctId":1363,"briefTitle":1364,"status":111,"phases":1365,"primaryCompletion":41,"completion":1366,"start":280,"enrollment":171,"conditions":1367,"interventions":1371},"NCT06086392","Perineural Dexamethasone in Supraclavicular Brachial Plexus Block for Anesthesia After Pediatric Hand\u002FWrist Surgery",[90],"2025-07-11",[880,1368,1369,1370,464],"Hand Injuries","Wrist Injuries","Hand Disease",[1275,1372],"0.05mg\u002Fkg Dexamethasone",{"nctId":1374,"briefTitle":1375,"status":111,"phases":1376,"primaryCompletion":1377,"completion":162,"start":280,"enrollment":171,"conditions":1378,"interventions":1380},"NCT06086418","Perineural Dexamethasone on the Duration of Popliteal Nerve Block for Anesthesia After Pediatric Ankle Surgery",[90],"2024-02-23",[350,1379,1272,351],"Ankle Injuries",[1381,1275,1372],"0.9 % Sodium Chloride",{"trials":1383,"activeCount":99},[],{"intervention":1287,"totalTrials":9,"cells":1385},{"EARLY_PHASE1":1386,"PHASE1":1388,"PHASE2":1390,"PHASE3":1392,"PHASE4":1394,"NA":1404},{"trials":1387,"activeCount":99},[],{"trials":1389,"activeCount":99},[],{"trials":1391,"activeCount":99},[],{"trials":1393,"activeCount":99},[],{"trials":1395,"activeCount":99},[1396,1400],{"nctId":1278,"briefTitle":1279,"status":111,"phases":1397,"primaryCompletion":1281,"completion":1282,"start":280,"enrollment":227,"conditions":1398,"interventions":1399},[90],[1284,1285],[1274,1287],{"nctId":1331,"briefTitle":1332,"status":111,"phases":1401,"primaryCompletion":1281,"completion":1282,"start":280,"enrollment":227,"conditions":1402,"interventions":1403},[90],[1285,408],[143,1287],{"trials":1405,"activeCount":99},[],{"intervention":1407,"totalTrials":9,"cells":1408},"perineural Dexamethasone 4mg",{"EARLY_PHASE1":1409,"PHASE1":1411,"PHASE2":1413,"PHASE3":1415,"PHASE4":1417,"NA":1433},{"trials":1410,"activeCount":99},[],{"trials":1412,"activeCount":99},[],{"trials":1414,"activeCount":99},[],{"trials":1416,"activeCount":99},[],{"trials":1418,"activeCount":99},[1419,1426],{"nctId":1420,"briefTitle":1421,"status":111,"phases":1422,"primaryCompletion":41,"completion":1366,"start":331,"enrollment":128,"conditions":1423,"interventions":1424},"NCT06789328","The Effect of Dexamethasone Administration Route on Pain and Inflammatory Response in PENG Block for Total Hip Arthroplasty",[90],[408,24,21,118],[1407,1425],"intravenous Dexamethsone 4mg",{"nctId":1427,"briefTitle":1428,"status":111,"phases":1429,"primaryCompletion":1430,"completion":308,"start":331,"enrollment":128,"conditions":1431,"interventions":1432},"NCT06789367","The Effect of Dexamethasone Administration Route in PENG Block for Pediatric Hip Surgery",[90],"2026-02-14",[229,541],[1407,1425],{"trials":1434,"activeCount":99},[],{"intervention":1425,"totalTrials":9,"cells":1436},{"EARLY_PHASE1":1437,"PHASE1":1439,"PHASE2":1441,"PHASE3":1443,"PHASE4":1445,"NA":1455},{"trials":1438,"activeCount":99},[],{"trials":1440,"activeCount":99},[],{"trials":1442,"activeCount":99},[],{"trials":1444,"activeCount":99},[],{"trials":1446,"activeCount":99},[1447,1451],{"nctId":1420,"briefTitle":1421,"status":111,"phases":1448,"primaryCompletion":41,"completion":1366,"start":331,"enrollment":128,"conditions":1449,"interventions":1450},[90],[408,24,21,118],[1407,1425],{"nctId":1427,"briefTitle":1428,"status":111,"phases":1452,"primaryCompletion":1430,"completion":308,"start":331,"enrollment":128,"conditions":1453,"interventions":1454},[90],[229,541],[1407,1425],{"trials":1456,"activeCount":99},[],{"intervention":1372,"totalTrials":9,"cells":1458},{"EARLY_PHASE1":1459,"PHASE1":1461,"PHASE2":1463,"PHASE3":1465,"PHASE4":1467,"NA":1477},{"trials":1460,"activeCount":99},[],{"trials":1462,"activeCount":99},[],{"trials":1464,"activeCount":99},[],{"trials":1466,"activeCount":99},[],{"trials":1468,"activeCount":99},[1469,1473],{"nctId":1363,"briefTitle":1364,"status":111,"phases":1470,"primaryCompletion":41,"completion":1366,"start":280,"enrollment":171,"conditions":1471,"interventions":1472},[90],[880,1368,1369,1370,464],[1275,1372],{"nctId":1374,"briefTitle":1375,"status":111,"phases":1474,"primaryCompletion":1377,"completion":162,"start":280,"enrollment":171,"conditions":1475,"interventions":1476},[90],[350,1379,1272,351],[1381,1275,1372],{"trials":1478,"activeCount":99},[],{"intervention":1480,"totalTrials":9,"cells":1481},"Ropivacaine",{"EARLY_PHASE1":1482,"PHASE1":1484,"PHASE2":1486,"PHASE3":1488,"PHASE4":1490,"NA":1507},{"trials":1483,"activeCount":99},[],{"trials":1485,"activeCount":99},[],{"trials":1487,"activeCount":99},[],{"trials":1489,"activeCount":99},[],{"trials":1491,"activeCount":99},[1492,1500],{"nctId":1493,"briefTitle":1494,"status":111,"phases":1495,"primaryCompletion":1268,"completion":1269,"start":1496,"enrollment":128,"conditions":1497,"interventions":1498},"NCT06470334","Dexamethasone With Ropivacaine for PENG Block in Total Hip Arthroplasty",[90],"2024-11-07",[15,24,118],[1480,1499],"Ropivacaine+Dexamethasone",{"nctId":1501,"briefTitle":1502,"status":111,"phases":1503,"primaryCompletion":1504,"completion":269,"start":127,"enrollment":128,"conditions":1505,"interventions":1506},"NCT06470204","Dexamethasone for iPACK Block With ACB in Total Knee Arthroplasty",[90],"2025-01-31",[18,27,32],[1480,1499],{"trials":1508,"activeCount":99},[],{"intervention":1499,"totalTrials":9,"cells":1510},{"EARLY_PHASE1":1511,"PHASE1":1513,"PHASE2":1515,"PHASE3":1517,"PHASE4":1519,"NA":1529},{"trials":1512,"activeCount":99},[],{"trials":1514,"activeCount":99},[],{"trials":1516,"activeCount":99},[],{"trials":1518,"activeCount":99},[],{"trials":1520,"activeCount":99},[1521,1525],{"nctId":1493,"briefTitle":1494,"status":111,"phases":1522,"primaryCompletion":1268,"completion":1269,"start":1496,"enrollment":128,"conditions":1523,"interventions":1524},[90],[15,24,118],[1480,1499],{"nctId":1501,"briefTitle":1502,"status":111,"phases":1526,"primaryCompletion":1504,"completion":269,"start":127,"enrollment":128,"conditions":1527,"interventions":1528},[90],[18,27,32],[1480,1499],{"trials":1530,"activeCount":99},[],{"intervention":1532,"totalTrials":9,"cells":1533},"Tranexamic acid",{"EARLY_PHASE1":1534,"PHASE1":1536,"PHASE2":1538,"PHASE3":1540,"PHASE4":1542,"NA":1561},{"trials":1535,"activeCount":99},[],{"trials":1537,"activeCount":99},[],{"trials":1539,"activeCount":99},[],{"trials":1541,"activeCount":99},[],{"trials":1543,"activeCount":99},[1544,1553],{"nctId":1545,"briefTitle":1546,"status":111,"phases":1547,"primaryCompletion":1075,"completion":1075,"start":1548,"enrollment":128,"conditions":1549,"interventions":1552},"NCT05945680","Tranexamic Acid in Breast Esthetic Surgery.",[90],"2023-09-15",[1550,1551],"Hemorrhage","Bleeding",[1532],{"nctId":1554,"briefTitle":1555,"status":111,"phases":1556,"primaryCompletion":1557,"completion":1557,"start":280,"enrollment":128,"conditions":1558,"interventions":1560},"NCT06086444","Tranexamic Acid in Abdominoplasty.",[90],"2025-10-10",[1559,1550,1551],"Abdominal Wall Defect",[1532],{"trials":1562,"activeCount":99},[],{"intervention":870,"totalTrials":9,"cells":1564},{"EARLY_PHASE1":1565,"PHASE1":1567,"PHASE2":1569,"PHASE3":1571,"PHASE4":1573,"NA":1583},{"trials":1566,"activeCount":99},[],{"trials":1568,"activeCount":99},[],{"trials":1570,"activeCount":99},[],{"trials":1572,"activeCount":99},[],{"trials":1574,"activeCount":99},[1575,1579],{"nctId":862,"briefTitle":863,"status":111,"phases":1576,"primaryCompletion":41,"completion":865,"start":280,"enrollment":171,"conditions":1577,"interventions":1578},[90],[350,867,351,868],[849,870,871],{"nctId":873,"briefTitle":874,"status":111,"phases":1580,"primaryCompletion":876,"completion":877,"start":878,"enrollment":171,"conditions":1581,"interventions":1582},[90],[880,464],[849,870,871],{"trials":1584,"activeCount":99},[],{"intervention":871,"totalTrials":9,"cells":1586},{"EARLY_PHASE1":1587,"PHASE1":1589,"PHASE2":1591,"PHASE3":1593,"PHASE4":1595,"NA":1605},{"trials":1588,"activeCount":99},[],{"trials":1590,"activeCount":99},[],{"trials":1592,"activeCount":99},[],{"trials":1594,"activeCount":99},[],{"trials":1596,"activeCount":99},[1597,1601],{"nctId":862,"briefTitle":863,"status":111,"phases":1598,"primaryCompletion":41,"completion":865,"start":280,"enrollment":171,"conditions":1599,"interventions":1600},[90],[350,867,351,868],[849,870,871],{"nctId":873,"briefTitle":874,"status":111,"phases":1602,"primaryCompletion":876,"completion":877,"start":878,"enrollment":171,"conditions":1603,"interventions":1604},[90],[880,464],[849,870,871],{"trials":1606,"activeCount":99},[],{"intervention":1276,"totalTrials":182,"cells":1608},{"EARLY_PHASE1":1609,"PHASE1":1611,"PHASE2":1613,"PHASE3":1615,"PHASE4":1617,"NA":1623},{"trials":1610,"activeCount":99},[],{"trials":1612,"activeCount":99},[],{"trials":1614,"activeCount":99},[],{"trials":1616,"activeCount":99},[],{"trials":1618,"activeCount":99},[1619],{"nctId":1265,"briefTitle":1266,"status":147,"phases":1620,"primaryCompletion":1268,"completion":1269,"start":1270,"enrollment":171,"conditions":1621,"interventions":1622},[90],[350,302,1272,351],[1274,1275,1276],{"trials":1624,"activeCount":99},[],{"intervention":381,"totalTrials":182,"cells":1626},{"EARLY_PHASE1":1627,"PHASE1":1629,"PHASE2":1631,"PHASE3":1633,"PHASE4":1635,"NA":1641},{"trials":1628,"activeCount":99},[],{"trials":1630,"activeCount":99},[],{"trials":1632,"activeCount":99},[],{"trials":1634,"activeCount":99},[],{"trials":1636,"activeCount":99},[1637],{"nctId":372,"briefTitle":373,"status":111,"phases":1638,"primaryCompletion":375,"completion":329,"start":376,"enrollment":171,"conditions":1639,"interventions":1640},[90],[378,27,379],[381,120,120],{"trials":1642,"activeCount":99},[],{"intervention":1644,"totalTrials":182,"cells":1645},"Atorvastatin",{"EARLY_PHASE1":1646,"PHASE1":1648,"PHASE2":1650,"PHASE3":1652,"PHASE4":1654,"NA":1669},{"trials":1647,"activeCount":99},[],{"trials":1649,"activeCount":99},[],{"trials":1651,"activeCount":99},[],{"trials":1653,"activeCount":99},[],{"trials":1655,"activeCount":99},[1656],{"nctId":1657,"briefTitle":1658,"status":111,"phases":1659,"primaryCompletion":1660,"completion":1660,"start":1661,"enrollment":1662,"conditions":1663,"interventions":1668},"NCT01448174","Salusin-alpha - a New Factor in the Pathogenesis of Lipid Abnormalities in Hemodialysis Patients",[90],"2014-10","2011-10",310,[1664,1665,1666,1667],"Renal Failure Chronic Requiring Hemodialysis","Metabolic Syndrome","Diabetes Mellitus Type 2","Hyperlipidemia",[1644],{"trials":1670,"activeCount":99},[],{"intervention":543,"totalTrials":182,"cells":1672},{"EARLY_PHASE1":1673,"PHASE1":1675,"PHASE2":1677,"PHASE3":1679,"PHASE4":1681,"NA":1687},{"trials":1674,"activeCount":99},[],{"trials":1676,"activeCount":99},[],{"trials":1678,"activeCount":99},[],{"trials":1680,"activeCount":99},[],{"trials":1682,"activeCount":99},[1683],{"nctId":533,"briefTitle":534,"status":111,"phases":1684,"primaryCompletion":536,"completion":537,"start":538,"enrollment":539,"conditions":1685,"interventions":1686},[90],[15,21,541,24],[79,543],{"trials":1688,"activeCount":99},[],{"intervention":1690,"totalTrials":182,"cells":1691},"Ropivacaine 0.5% Injectable Solution 20mL",{"EARLY_PHASE1":1692,"PHASE1":1694,"PHASE2":1696,"PHASE3":1698,"PHASE4":1700,"NA":1711},{"trials":1693,"activeCount":99},[],{"trials":1695,"activeCount":99},[],{"trials":1697,"activeCount":99},[],{"trials":1699,"activeCount":99},[],{"trials":1701,"activeCount":99},[1702],{"nctId":1703,"briefTitle":1704,"status":147,"phases":1705,"primaryCompletion":149,"completion":1706,"start":538,"enrollment":1707,"conditions":1708,"interventions":1709},"NCT06087562","iPACK Block for Total Knee Arthroplasty",[90],"2024-12-30",350,[18,27,153],[1690,1710],"0,9% normal saline 20mL",{"trials":1712,"activeCount":99},[],{"intervention":1710,"totalTrials":182,"cells":1714},{"EARLY_PHASE1":1715,"PHASE1":1717,"PHASE2":1719,"PHASE3":1721,"PHASE4":1723,"NA":1729},{"trials":1716,"activeCount":99},[],{"trials":1718,"activeCount":99},[],{"trials":1720,"activeCount":99},[],{"trials":1722,"activeCount":99},[],{"trials":1724,"activeCount":99},[1725],{"nctId":1703,"briefTitle":1704,"status":147,"phases":1726,"primaryCompletion":149,"completion":1706,"start":538,"enrollment":1707,"conditions":1727,"interventions":1728},[90],[18,27,153],[1690,1710],{"trials":1730,"activeCount":99},[],{"intervention":1732,"totalTrials":182,"cells":1733},"Simvastatin and micronized trans-resveratrol",{"EARLY_PHASE1":1734,"PHASE1":1736,"PHASE2":1738,"PHASE3":1740,"PHASE4":1742,"NA":1754},{"trials":1735,"activeCount":99},[],{"trials":1737,"activeCount":99},[],{"trials":1739,"activeCount":99},[],{"trials":1741,"activeCount":99},[],{"trials":1743,"activeCount":99},[1744],{"nctId":1745,"briefTitle":1746,"status":147,"phases":1747,"primaryCompletion":1748,"completion":1749,"start":1750,"enrollment":128,"conditions":1751,"interventions":1753},"NCT02766803","Effects of Simvastatin and Micronized Trans-resveratrol Treatment on Polycystic Ovary Syndrome (PCOS) Patients",[90],"2017-06","2018-06","2016-05",[1752],"PCOS, Insulin Resistance",[1732],{"trials":1755,"activeCount":99},[],{"intervention":1757,"totalTrials":182,"cells":1758},"Ropivacaine 0.2% Injectable Solution Erector Spinae Plane Block",{"EARLY_PHASE1":1759,"PHASE1":1761,"PHASE2":1763,"PHASE3":1765,"PHASE4":1767,"NA":1778},{"trials":1760,"activeCount":99},[],{"trials":1762,"activeCount":99},[],{"trials":1764,"activeCount":99},[],{"trials":1766,"activeCount":99},[],{"trials":1768,"activeCount":99},[1769],{"nctId":1770,"briefTitle":1771,"status":111,"phases":1772,"primaryCompletion":1773,"completion":1773,"start":280,"enrollment":171,"conditions":1774,"interventions":1775},"NCT06083428","Erector Spinae vs. PENG Block for Total Hip Arthroplasty",[90],"2024-06-11",[21,15,24],[1757,1776,1777],"Ropivacaine 0.2% Injectable Solution - PENG block","Control Test",{"trials":1779,"activeCount":99},[],{"intervention":1776,"totalTrials":182,"cells":1781},{"EARLY_PHASE1":1782,"PHASE1":1784,"PHASE2":1786,"PHASE3":1788,"PHASE4":1790,"NA":1796},{"trials":1783,"activeCount":99},[],{"trials":1785,"activeCount":99},[],{"trials":1787,"activeCount":99},[],{"trials":1789,"activeCount":99},[],{"trials":1791,"activeCount":99},[1792],{"nctId":1770,"briefTitle":1771,"status":111,"phases":1793,"primaryCompletion":1773,"completion":1773,"start":280,"enrollment":171,"conditions":1794,"interventions":1795},[90],[21,15,24],[1757,1776,1777],{"trials":1797,"activeCount":99},[],{"intervention":1777,"totalTrials":182,"cells":1799},{"EARLY_PHASE1":1800,"PHASE1":1802,"PHASE2":1804,"PHASE3":1806,"PHASE4":1808,"NA":1814},{"trials":1801,"activeCount":99},[],{"trials":1803,"activeCount":99},[],{"trials":1805,"activeCount":99},[],{"trials":1807,"activeCount":99},[],{"trials":1809,"activeCount":99},[1810],{"nctId":1770,"briefTitle":1771,"status":111,"phases":1811,"primaryCompletion":1773,"completion":1773,"start":280,"enrollment":171,"conditions":1812,"interventions":1813},[90],[21,15,24],[1757,1776,1777],{"trials":1815,"activeCount":99},[],{"intervention":131,"totalTrials":182,"cells":1817},{"EARLY_PHASE1":1818,"PHASE1":1820,"PHASE2":1822,"PHASE3":1824,"PHASE4":1826,"NA":1832},{"trials":1819,"activeCount":99},[],{"trials":1821,"activeCount":99},[],{"trials":1823,"activeCount":99},[],{"trials":1825,"activeCount":99},[],{"trials":1827,"activeCount":99},[1828],{"nctId":122,"briefTitle":123,"status":111,"phases":1829,"primaryCompletion":125,"completion":126,"start":127,"enrollment":128,"conditions":1830,"interventions":1831},[90],[15,21,24],[94,131],{"trials":1833,"activeCount":99},[],{"intervention":1835,"totalTrials":182,"cells":1836},"Control Test - spinal anesthesia",{"EARLY_PHASE1":1837,"PHASE1":1839,"PHASE2":1841,"PHASE3":1843,"PHASE4":1845,"NA":1857},{"trials":1838,"activeCount":99},[],{"trials":1840,"activeCount":99},[],{"trials":1842,"activeCount":99},[],{"trials":1844,"activeCount":99},[],{"trials":1846,"activeCount":99},[1847],{"nctId":1848,"briefTitle":1849,"status":111,"phases":1850,"primaryCompletion":1851,"completion":1852,"start":162,"enrollment":171,"conditions":1853,"interventions":1854},"NCT06233630","Erector Spinae Plane Block Vs. IPACK Block with Adductor Canal Block for Total Knee Arthroplasty",[90],"2024-08-16","2024-08-20",[18,27,32],[1835,1855,1856],"Ropivacaine 0.2% Injectable Solution ESPB","Ropivacaine 0.2% Injectable Solution iPACK+ACB",{"trials":1858,"activeCount":99},[],{"intervention":1855,"totalTrials":182,"cells":1860},{"EARLY_PHASE1":1861,"PHASE1":1863,"PHASE2":1865,"PHASE3":1867,"PHASE4":1869,"NA":1875},{"trials":1862,"activeCount":99},[],{"trials":1864,"activeCount":99},[],{"trials":1866,"activeCount":99},[],{"trials":1868,"activeCount":99},[],{"trials":1870,"activeCount":99},[1871],{"nctId":1848,"briefTitle":1849,"status":111,"phases":1872,"primaryCompletion":1851,"completion":1852,"start":162,"enrollment":171,"conditions":1873,"interventions":1874},[90],[18,27,32],[1835,1855,1856],{"trials":1876,"activeCount":99},[],{"intervention":1856,"totalTrials":182,"cells":1878},{"EARLY_PHASE1":1879,"PHASE1":1881,"PHASE2":1883,"PHASE3":1885,"PHASE4":1887,"NA":1893},{"trials":1880,"activeCount":99},[],{"trials":1882,"activeCount":99},[],{"trials":1884,"activeCount":99},[],{"trials":1886,"activeCount":99},[],{"trials":1888,"activeCount":99},[1889],{"nctId":1848,"briefTitle":1849,"status":111,"phases":1890,"primaryCompletion":1851,"completion":1852,"start":162,"enrollment":171,"conditions":1891,"interventions":1892},[90],[18,27,32],[1835,1855,1856],{"trials":1894,"activeCount":99},[],{"intervention":156,"totalTrials":182,"cells":1896},{"EARLY_PHASE1":1897,"PHASE1":1899,"PHASE2":1901,"PHASE3":1903,"PHASE4":1905,"NA":1911},{"trials":1898,"activeCount":99},[],{"trials":1900,"activeCount":99},[],{"trials":1902,"activeCount":99},[],{"trials":1904,"activeCount":99},[],{"trials":1906,"activeCount":99},[1907],{"nctId":145,"briefTitle":146,"status":147,"phases":1908,"primaryCompletion":149,"completion":150,"start":151,"enrollment":128,"conditions":1909,"interventions":1910},[90],[32,141,18,27,153,154],[94,94,156],{"trials":1912,"activeCount":99},[],{"intervention":1381,"totalTrials":182,"cells":1914},{"EARLY_PHASE1":1915,"PHASE1":1917,"PHASE2":1919,"PHASE3":1921,"PHASE4":1923,"NA":1929},{"trials":1916,"activeCount":99},[],{"trials":1918,"activeCount":99},[],{"trials":1920,"activeCount":99},[],{"trials":1922,"activeCount":99},[],{"trials":1924,"activeCount":99},[1925],{"nctId":1374,"briefTitle":1375,"status":111,"phases":1926,"primaryCompletion":1377,"completion":162,"start":280,"enrollment":171,"conditions":1927,"interventions":1928},[90],[350,1379,1272,351],[1381,1275,1372],{"trials":1930,"activeCount":99},[],{"intervention":1932,"totalTrials":182,"cells":1933},"2 x 20 ml of Ropivacaine 0.2% Injectable Solution",{"EARLY_PHASE1":1934,"PHASE1":1936,"PHASE2":1938,"PHASE3":1940,"PHASE4":1942,"NA":1952},{"trials":1935,"activeCount":99},[],{"trials":1937,"activeCount":99},[],{"trials":1939,"activeCount":99},[],{"trials":1941,"activeCount":99},[],{"trials":1943,"activeCount":99},[1944],{"nctId":1945,"briefTitle":1946,"status":111,"phases":1947,"primaryCompletion":1948,"completion":1948,"start":1496,"enrollment":128,"conditions":1949,"interventions":1950},"NCT06470542","Two-level ESPB in Total Knee Arthroplasty",[90],"2025-08-05",[18,27,32],[1932,1951],"2 x 20ml of Ropivacaine 0.2% Injectable Solution",{"trials":1953,"activeCount":99},[],{"intervention":1951,"totalTrials":182,"cells":1955},{"EARLY_PHASE1":1956,"PHASE1":1958,"PHASE2":1960,"PHASE3":1962,"PHASE4":1964,"NA":1970},{"trials":1957,"activeCount":99},[],{"trials":1959,"activeCount":99},[],{"trials":1961,"activeCount":99},[],{"trials":1963,"activeCount":99},[],{"trials":1965,"activeCount":99},[1966],{"nctId":1945,"briefTitle":1946,"status":111,"phases":1967,"primaryCompletion":1948,"completion":1948,"start":1496,"enrollment":128,"conditions":1968,"interventions":1969},[90],[18,27,32],[1932,1951],{"trials":1971,"activeCount":99},[],{"intervention":1973,"totalTrials":182,"cells":1974},"Sham block",{"EARLY_PHASE1":1975,"PHASE1":1977,"PHASE2":1979,"PHASE3":1981,"PHASE4":1983,"NA":1995},{"trials":1976,"activeCount":99},[],{"trials":1978,"activeCount":99},[],{"trials":1980,"activeCount":99},[],{"trials":1982,"activeCount":99},[],{"trials":1984,"activeCount":99},[1985],{"nctId":1986,"briefTitle":1987,"status":147,"phases":1988,"primaryCompletion":1989,"completion":1990,"start":1991,"enrollment":227,"conditions":1992,"interventions":1993},"NCT05938959","Erector Spinae Plane Block for Pediatric Idiopathic Scoliosis Surgery",[90],"2024-07-30","2024-09-01","2023-05-01",[282],[1973,1994],"ESPB",{"trials":1996,"activeCount":99},[],{"intervention":1994,"totalTrials":182,"cells":1998},{"EARLY_PHASE1":1999,"PHASE1":2001,"PHASE2":2003,"PHASE3":2005,"PHASE4":2007,"NA":2013},{"trials":2000,"activeCount":99},[],{"trials":2002,"activeCount":99},[],{"trials":2004,"activeCount":99},[],{"trials":2006,"activeCount":99},[],{"trials":2008,"activeCount":99},[2009],{"nctId":1986,"briefTitle":1987,"status":147,"phases":2010,"primaryCompletion":1989,"completion":1990,"start":1991,"enrollment":227,"conditions":2011,"interventions":2012},[90],[282],[1973,1994],{"trials":2014,"activeCount":99},[],{"intervention":2016,"totalTrials":182,"cells":2017},"Eplerenone 50 mg Tab",{"EARLY_PHASE1":2018,"PHASE1":2020,"PHASE2":2022,"PHASE3":2024,"PHASE4":2026,"NA":2041},{"trials":2019,"activeCount":99},[],{"trials":2021,"activeCount":99},[],{"trials":2023,"activeCount":99},[],{"trials":2025,"activeCount":99},[],{"trials":2027,"activeCount":99},[2028],{"nctId":2029,"briefTitle":2030,"status":111,"phases":2031,"primaryCompletion":2032,"completion":2033,"start":2034,"enrollment":2035,"conditions":2036,"interventions":2040},"NCT03186742","Reduction of Left Ventricular Hypertrophy After Eplerenone Therapy",[90],"2017-01-01","2017-06-01","2014-07-01",125,[2037,2038,2039],"Hypertension,Essential","Obstructive Sleep Apnea","Left Ventricular Hypertrophy",[2016],{"trials":2042,"activeCount":99},[],{"intervention":2044,"totalTrials":182,"cells":2045},"Cerebrolysin",{"EARLY_PHASE1":2046,"PHASE1":2048,"PHASE2":2050,"PHASE3":2052,"PHASE4":2054,"NA":2064},{"trials":2047,"activeCount":99},[],{"trials":2049,"activeCount":99},[],{"trials":2051,"activeCount":99},[],{"trials":2053,"activeCount":99},[],{"trials":2055,"activeCount":99},[2056],{"nctId":2057,"briefTitle":2058,"status":147,"phases":2059,"primaryCompletion":1504,"completion":1268,"start":2060,"enrollment":1707,"conditions":2061,"interventions":2063},"NCT06078215","CERebrolysine Effect on Blood-brain Barrier in acUte Ischemic Stroke",[90],"2023-01-10",[2062],"Acute Ischemic Stroke",[2044],{"trials":2065,"activeCount":99},[],{"intervention":2067,"totalTrials":182,"cells":2068},"Oxycodone 10mg",{"EARLY_PHASE1":2069,"PHASE1":2071,"PHASE2":2073,"PHASE3":2075,"PHASE4":2077,"NA":2091},{"trials":2070,"activeCount":99},[],{"trials":2072,"activeCount":99},[],{"trials":2074,"activeCount":99},[],{"trials":2076,"activeCount":99},[],{"trials":2078,"activeCount":99},[2079],{"nctId":2080,"briefTitle":2081,"status":111,"phases":2082,"primaryCompletion":2083,"completion":2084,"start":2085,"enrollment":2086,"conditions":2087,"interventions":2089},"NCT06142591","Oxycodone (10, 20 mg) in a Postoperative Dressing",[90],"2018-02-28","2022-03-03","2016-01-01",20,[2088],"Burns",[2067,2090],"Oxycodone 20mg",{"trials":2092,"activeCount":99},[],{"intervention":2090,"totalTrials":182,"cells":2094},{"EARLY_PHASE1":2095,"PHASE1":2097,"PHASE2":2099,"PHASE3":2101,"PHASE4":2103,"NA":2109},{"trials":2096,"activeCount":99},[],{"trials":2098,"activeCount":99},[],{"trials":2100,"activeCount":99},[],{"trials":2102,"activeCount":99},[],{"trials":2104,"activeCount":99},[2105],{"nctId":2080,"briefTitle":2081,"status":111,"phases":2106,"primaryCompletion":2083,"completion":2084,"start":2085,"enrollment":2086,"conditions":2107,"interventions":2108},[90],[2088],[2067,2090],{"trials":2110,"activeCount":99},[],{"intervention":2112,"totalTrials":182,"cells":2113},"Pericapsular nerve group block using 0.2% ropivacaine",{"EARLY_PHASE1":2114,"PHASE1":2116,"PHASE2":2118,"PHASE3":2120,"PHASE4":2122,"NA":2133},{"trials":2115,"activeCount":99},[],{"trials":2117,"activeCount":99},[],{"trials":2119,"activeCount":99},[],{"trials":2121,"activeCount":99},[],{"trials":2123,"activeCount":99},[2124],{"nctId":2125,"briefTitle":2126,"status":111,"phases":2127,"primaryCompletion":1377,"completion":1377,"start":280,"enrollment":171,"conditions":2128,"interventions":2131},"NCT06087549","PENG Block vs. ESP Block for Pediatric Hip Surgery",[90],[229,2129,2130,541],"Hip Injuries","Hip Fractures",[2112,2132],"Erector Spinae Plane Block using 0.2% ropivacaine",{"trials":2134,"activeCount":99},[],{"intervention":2132,"totalTrials":182,"cells":2136},{"EARLY_PHASE1":2137,"PHASE1":2139,"PHASE2":2141,"PHASE3":2143,"PHASE4":2145,"NA":2151},{"trials":2138,"activeCount":99},[],{"trials":2140,"activeCount":99},[],{"trials":2142,"activeCount":99},[],{"trials":2144,"activeCount":99},[],{"trials":2146,"activeCount":99},[2147],{"nctId":2125,"briefTitle":2126,"status":111,"phases":2148,"primaryCompletion":1377,"completion":1377,"start":280,"enrollment":171,"conditions":2149,"interventions":2150},[90],[229,2129,2130,541],[2112,2132],{"trials":2152,"activeCount":99},[],{"intervention":324,"totalTrials":182,"cells":2154},{"EARLY_PHASE1":2155,"PHASE1":2157,"PHASE2":2159,"PHASE3":2161,"PHASE4":2163,"NA":2169},{"trials":2156,"activeCount":99},[],{"trials":2158,"activeCount":99},[],{"trials":2160,"activeCount":99},[],{"trials":2162,"activeCount":99},[],{"trials":2164,"activeCount":99},[2165],{"nctId":313,"briefTitle":314,"status":111,"phases":2166,"primaryCompletion":316,"completion":317,"start":318,"enrollment":171,"conditions":2167,"interventions":2168},[90],[320,251,321,322],[165,324,196],{"trials":2170,"activeCount":99},[],{"intervention":2172,"totalTrials":182,"cells":2173},"Poractant alfa instillation",{"EARLY_PHASE1":2174,"PHASE1":2176,"PHASE2":2178,"PHASE3":2180,"PHASE4":2182,"NA":2196},{"trials":2175,"activeCount":99},[],{"trials":2177,"activeCount":99},[],{"trials":2179,"activeCount":99},[],{"trials":2181,"activeCount":99},[],{"trials":2183,"activeCount":99},[2184],{"nctId":2185,"briefTitle":2186,"status":111,"phases":2187,"primaryCompletion":2188,"completion":2188,"start":2189,"enrollment":2190,"conditions":2191,"interventions":2194},"NCT01941524","Brain Oxygenation and Function of Preterm Newborns During Administration of Two Different Surfactant Preparations",[90],"2015-06-20","2013-03-03",22,[2192,2193],"Respiratory Distress Syndrome, Newborn","Respiratory Failure",[2172,2195],"Beractant instillation",{"trials":2197,"activeCount":99},[],{"intervention":2195,"totalTrials":182,"cells":2199},{"EARLY_PHASE1":2200,"PHASE1":2202,"PHASE2":2204,"PHASE3":2206,"PHASE4":2208,"NA":2214},{"trials":2201,"activeCount":99},[],{"trials":2203,"activeCount":99},[],{"trials":2205,"activeCount":99},[],{"trials":2207,"activeCount":99},[],{"trials":2209,"activeCount":99},[2210],{"nctId":2185,"briefTitle":2186,"status":111,"phases":2211,"primaryCompletion":2188,"completion":2188,"start":2189,"enrollment":2190,"conditions":2212,"interventions":2213},[90],[2192,2193],[2172,2195],{"trials":2215,"activeCount":99},[],{"intervention":2217,"totalTrials":182,"cells":2218},"Ibuprofen",{"EARLY_PHASE1":2219,"PHASE1":2221,"PHASE2":2223,"PHASE3":2236,"PHASE4":2238,"NA":2240},{"trials":2220,"activeCount":99},[],{"trials":2222,"activeCount":99},[],{"trials":2224,"activeCount":99},[2225],{"nctId":2226,"briefTitle":2227,"status":147,"phases":2228,"primaryCompletion":2229,"completion":2229,"start":2230,"enrollment":2086,"conditions":2231,"interventions":2235},"NCT04485403","The Effect of Ibuprofen on Women With PCOS.",[88],"2021-12-01","2019-09-01",[2232,2233,2234],"PCOS","Hyperandrogenism","Inflammation",[2217],{"trials":2237,"activeCount":99},[],{"trials":2239,"activeCount":99},[],{"trials":2241,"activeCount":99},[],{"intervention":2243,"totalTrials":182,"cells":2244},"The cream base formulation containing oil phase, Creagel EZ® 7 and Alphaflow® 20",{"EARLY_PHASE1":2245,"PHASE1":2247,"PHASE2":2249,"PHASE3":2263,"PHASE4":2265,"NA":2267},{"trials":2246,"activeCount":99},[],{"trials":2248,"activeCount":99},[],{"trials":2250,"activeCount":99},[2251],{"nctId":2252,"briefTitle":2253,"status":111,"phases":2254,"primaryCompletion":2255,"completion":2256,"start":2257,"enrollment":2086,"conditions":2258,"interventions":2260},"NCT07359924","PRF in Face Care Cream.",[88],"2022-08-08","2023-02-06","2022-02-03",[2259],"Skin Ageing",[2243,2261,2262],"The cream base formulation containing oil phase, Creagel EZ® 7 and Alphaflow® 20 with additional growth factor EGF","The cream base formulation containing oil phase, Creagel EZ® 7 and Alphaflow® 20 with autologus PRF",{"trials":2264,"activeCount":99},[],{"trials":2266,"activeCount":99},[],{"trials":2268,"activeCount":99},[],{"intervention":2261,"totalTrials":182,"cells":2270},{"EARLY_PHASE1":2271,"PHASE1":2273,"PHASE2":2275,"PHASE3":2281,"PHASE4":2283,"NA":2285},{"trials":2272,"activeCount":99},[],{"trials":2274,"activeCount":99},[],{"trials":2276,"activeCount":99},[2277],{"nctId":2252,"briefTitle":2253,"status":111,"phases":2278,"primaryCompletion":2255,"completion":2256,"start":2257,"enrollment":2086,"conditions":2279,"interventions":2280},[88],[2259],[2243,2261,2262],{"trials":2282,"activeCount":99},[],{"trials":2284,"activeCount":99},[],{"trials":2286,"activeCount":99},[],{"intervention":2262,"totalTrials":182,"cells":2288},{"EARLY_PHASE1":2289,"PHASE1":2291,"PHASE2":2293,"PHASE3":2299,"PHASE4":2301,"NA":2303},{"trials":2290,"activeCount":99},[],{"trials":2292,"activeCount":99},[],{"trials":2294,"activeCount":99},[2295],{"nctId":2252,"briefTitle":2253,"status":111,"phases":2296,"primaryCompletion":2255,"completion":2256,"start":2257,"enrollment":2086,"conditions":2297,"interventions":2298},[88],[2259],[2243,2261,2262],{"trials":2300,"activeCount":99},[],{"trials":2302,"activeCount":99},[],{"trials":2304,"activeCount":99},[],{"intervention":2306,"totalTrials":182,"cells":2307},"heliox",{"EARLY_PHASE1":2308,"PHASE1":2310,"PHASE2":2312,"PHASE3":2325,"PHASE4":2327,"NA":2329},{"trials":2309,"activeCount":99},[],{"trials":2311,"activeCount":99},[],{"trials":2313,"activeCount":99},[2314],{"nctId":2315,"briefTitle":2316,"status":111,"phases":2317,"primaryCompletion":2318,"completion":2318,"start":2319,"enrollment":2320,"conditions":2321,"interventions":2324},"NCT04404816","Effects of Non-invasive Ventilation With Helium-oxygen Mixture in Premature Infants With Respiratory Distress Syndrome",[87,88],"2018-12","2017-01",23,[2322,2323],"Respiratory Distress Syndrome","Premature Infants",[2306],{"trials":2326,"activeCount":99},[],{"trials":2328,"activeCount":99},[],{"trials":2330,"activeCount":99},[],{"intervention":2332,"totalTrials":9,"cells":2333},"Simvastatin",{"EARLY_PHASE1":2334,"PHASE1":2336,"PHASE2":2338,"PHASE3":2340,"PHASE4":2342,"NA":2344},{"trials":2335,"activeCount":99},[],{"trials":2337,"activeCount":99},[],{"trials":2339,"activeCount":99},[],{"trials":2341,"activeCount":99},[],{"trials":2343,"activeCount":99},[],{"trials":2345,"activeCount":99},[2346,2356],{"nctId":2347,"briefTitle":2348,"status":147,"phases":2349,"start":2350,"conditions":2351,"interventions":2353},"NCT00396513","Simvastatin and Metformin Therapy in PCOS Women. Prospective Randomised Trial.",[91],"2005-09",[2352],"Polycystic Ovary Syndrome",[2332,2354,2355],"Simvastatin and Metformin","Metformin",{"nctId":2357,"briefTitle":2358,"status":111,"phases":2359,"completion":2360,"start":2361,"conditions":2362,"interventions":2363},"NCT00365638","Simvastatin Therapy in Women With Polycystic Ovary Syndrome.",[91],"2005-02","2004-04",[2352],[2364],"simvastatin",{"intervention":2366,"totalTrials":182,"cells":2367},"MetFORMIN 500 Mg Oral",{"EARLY_PHASE1":2368,"PHASE1":2370,"PHASE2":2372,"PHASE3":2374,"PHASE4":2376,"NA":2378},{"trials":2369,"activeCount":99},[],{"trials":2371,"activeCount":99},[],{"trials":2373,"activeCount":99},[],{"trials":2375,"activeCount":99},[],{"trials":2377,"activeCount":99},[],{"trials":2379,"activeCount":99},[2380],{"nctId":2381,"briefTitle":2382,"status":147,"phases":2383,"primaryCompletion":2384,"completion":2385,"start":2386,"enrollment":227,"conditions":2387,"interventions":2388},"NCT03489668","Androgen Responses to hCG and Ovarian Morphology in PCOS",[91],"2020-01-31","2020-03-31","2018-01-20",[2232],[2366],{"intervention":2390,"totalTrials":182,"cells":2391},"gene expression",{"EARLY_PHASE1":2392,"PHASE1":2394,"PHASE2":2396,"PHASE3":2398,"PHASE4":2400,"NA":2402},{"trials":2393,"activeCount":99},[],{"trials":2395,"activeCount":99},[],{"trials":2397,"activeCount":99},[],{"trials":2399,"activeCount":99},[],{"trials":2401,"activeCount":99},[],{"trials":2403,"activeCount":99},[2404],{"nctId":2405,"briefTitle":2406,"status":111,"phases":2407,"primaryCompletion":2408,"completion":2409,"start":2408,"enrollment":2410,"conditions":2411,"interventions":2413},"NCT04077554","Relationship Between the VEGF Gene Polymorphism and Cardiometabolic Risk Factors",[],"2018-01-01","2019-08-30",400,[2412],"Polymorphism, Restriction Fragment Length",[2390],{"intervention":2415,"totalTrials":182,"cells":2416},"Epidural administration of sufentanil",{"EARLY_PHASE1":2417,"PHASE1":2419,"PHASE2":2421,"PHASE3":2423,"PHASE4":2425,"NA":2427},{"trials":2418,"activeCount":99},[],{"trials":2420,"activeCount":99},[],{"trials":2422,"activeCount":99},[],{"trials":2424,"activeCount":99},[],{"trials":2426,"activeCount":99},[],{"trials":2428,"activeCount":99},[2429],{"nctId":2430,"briefTitle":2431,"status":111,"phases":2432,"primaryCompletion":2433,"completion":2434,"start":2435,"enrollment":16,"conditions":2436,"interventions":2440},"NCT06069219","Pharmacokinetics of Sufentanil After Epidural Administration",[],"2020-02-28","2023-01-31","2019-06-01",[2437,2438,2439],"Epidural; Anesthesia","Epidural Analgesia","Abdominal Surgery",[2415],{"intervention":2442,"totalTrials":182,"cells":2443},"Sugammadex",{"EARLY_PHASE1":2444,"PHASE1":2446,"PHASE2":2448,"PHASE3":2450,"PHASE4":2452,"NA":2454},{"trials":2445,"activeCount":99},[],{"trials":2447,"activeCount":99},[],{"trials":2449,"activeCount":99},[],{"trials":2451,"activeCount":99},[],{"trials":2453,"activeCount":99},[],{"trials":2455,"activeCount":99},[2456],{"nctId":2457,"briefTitle":2458,"status":111,"phases":2459,"primaryCompletion":2460,"completion":2461,"start":2462,"enrollment":2463,"conditions":2464,"interventions":2466},"NCT04851574","PKPD of Rocuronium and Sugammadex Profile in Pediatric Patients",[],"2020-01-20","2020-01-29","2017-10-27",37,[2465],"General Anesthetic Drug Adverse Reaction",[2442],{"intervention":2468,"totalTrials":182,"cells":2469},"oral contraceptive",{"EARLY_PHASE1":2470,"PHASE1":2472,"PHASE2":2474,"PHASE3":2476,"PHASE4":2478,"NA":2480},{"trials":2471,"activeCount":99},[],{"trials":2473,"activeCount":99},[],{"trials":2475,"activeCount":99},[],{"trials":2477,"activeCount":99},[],{"trials":2479,"activeCount":99},[],{"trials":2481,"activeCount":99},[2482],{"nctId":2483,"briefTitle":2484,"status":147,"phases":2485,"primaryCompletion":2486,"completion":2487,"start":2488,"enrollment":2489,"conditions":2490,"interventions":2493},"NCT00675779","Efficacy Study of Atorvastatin in Pelvic Pain Relief in Women With Endometriosis",[91],"2010-11","2011-03","2008-04",44,[2491,2492],"Endometriosis","Pain",[2468,2494],"atorvastatin + oral contraceptive",{"intervention":2494,"totalTrials":182,"cells":2496},{"EARLY_PHASE1":2497,"PHASE1":2499,"PHASE2":2501,"PHASE3":2503,"PHASE4":2505,"NA":2507},{"trials":2498,"activeCount":99},[],{"trials":2500,"activeCount":99},[],{"trials":2502,"activeCount":99},[],{"trials":2504,"activeCount":99},[],{"trials":2506,"activeCount":99},[],{"trials":2508,"activeCount":99},[2509],{"nctId":2483,"briefTitle":2484,"status":147,"phases":2510,"primaryCompletion":2486,"completion":2487,"start":2488,"enrollment":2489,"conditions":2511,"interventions":2512},[91],[2491,2492],[2468,2494],{"intervention":2514,"totalTrials":182,"cells":2515},"Infusion Intravenous",{"EARLY_PHASE1":2516,"PHASE1":2518,"PHASE2":2520,"PHASE3":2522,"PHASE4":2524,"NA":2526},{"trials":2517,"activeCount":99},[],{"trials":2519,"activeCount":99},[],{"trials":2521,"activeCount":99},[],{"trials":2523,"activeCount":99},[],{"trials":2525,"activeCount":99},[],{"trials":2527,"activeCount":99},[2528],{"nctId":2529,"briefTitle":2530,"status":111,"phases":2531,"primaryCompletion":2532,"completion":2533,"start":2534,"enrollment":2190,"conditions":2535,"interventions":2538},"NCT04866498","Pharmacotherapy Personalization of Cancer Patients",[],"2019-06-30","2021-03-31","2016-07-01",[2536,2537],"Head and Neck Neoplasms","Oncologic Patients",[2514],{"intervention":2354,"totalTrials":182,"cells":2540},{"EARLY_PHASE1":2541,"PHASE1":2543,"PHASE2":2545,"PHASE3":2547,"PHASE4":2549,"NA":2551},{"trials":2542,"activeCount":99},[],{"trials":2544,"activeCount":99},[],{"trials":2546,"activeCount":99},[],{"trials":2548,"activeCount":99},[],{"trials":2550,"activeCount":99},[],{"trials":2552,"activeCount":99},[2553],{"nctId":2347,"briefTitle":2348,"status":147,"phases":2554,"start":2350,"conditions":2555,"interventions":2556},[91],[2352],[2332,2354,2355],{"intervention":2355,"totalTrials":182,"cells":2558},{"EARLY_PHASE1":2559,"PHASE1":2561,"PHASE2":2563,"PHASE3":2565,"PHASE4":2567,"NA":2569},{"trials":2560,"activeCount":99},[],{"trials":2562,"activeCount":99},[],{"trials":2564,"activeCount":99},[],{"trials":2566,"activeCount":99},[],{"trials":2568,"activeCount":99},[],{"trials":2570,"activeCount":99},[2571],{"nctId":2347,"briefTitle":2348,"status":147,"phases":2572,"start":2350,"conditions":2573,"interventions":2574},[91],[2352],[2332,2354,2355],{"intervention":245,"totalTrials":182,"cells":2576},{"EARLY_PHASE1":2577,"PHASE1":2579,"PHASE2":2581,"PHASE3":2583,"PHASE4":2585,"NA":2587},{"trials":2578,"activeCount":99},[],{"trials":2580,"activeCount":99},[],{"trials":2582,"activeCount":99},[],{"trials":2584,"activeCount":99},[],{"trials":2586,"activeCount":99},[],{"trials":2588,"activeCount":99},[2589],{"nctId":232,"briefTitle":233,"status":147,"phases":2590,"primaryCompletion":235,"completion":236,"start":237,"enrollment":238,"conditions":2591,"interventions":2592},[91],[240,241,242,243],[94,245],{"intervention":2594,"totalTrials":182,"cells":2595},"Rivaroxaban",{"EARLY_PHASE1":2596,"PHASE1":2598,"PHASE2":2600,"PHASE3":2602,"PHASE4":2604,"NA":2606},{"trials":2597,"activeCount":99},[],{"trials":2599,"activeCount":99},[],{"trials":2601,"activeCount":99},[],{"trials":2603,"activeCount":99},[],{"trials":2605,"activeCount":99},[],{"trials":2607,"activeCount":99},[2608],{"nctId":2609,"briefTitle":2610,"status":147,"phases":2611,"primaryCompletion":2612,"completion":2613,"start":2614,"enrollment":227,"conditions":2615,"interventions":2617},"NCT04305028","Influence of Rivaroxaban for Intermittent Claudication and Exercise Tolerance in Patients With Symptomatic PAD",[],"2021-12-31","2024-12-31","2021-03-10",[2616],"Peripheral Arterial Disease",[2594,2618],"Aspirin",{"intervention":2618,"totalTrials":182,"cells":2620},{"EARLY_PHASE1":2621,"PHASE1":2623,"PHASE2":2625,"PHASE3":2627,"PHASE4":2629,"NA":2631},{"trials":2622,"activeCount":99},[],{"trials":2624,"activeCount":99},[],{"trials":2626,"activeCount":99},[],{"trials":2628,"activeCount":99},[],{"trials":2630,"activeCount":99},[],{"trials":2632,"activeCount":99},[2633],{"nctId":2609,"briefTitle":2610,"status":147,"phases":2634,"primaryCompletion":2612,"completion":2613,"start":2614,"enrollment":227,"conditions":2635,"interventions":2636},[],[2616],[2594,2618],{"intervention":2638,"totalTrials":182,"cells":2639},"Lynparza®",{"EARLY_PHASE1":2640,"PHASE1":2642,"PHASE2":2644,"PHASE3":2646,"PHASE4":2648,"NA":2650},{"trials":2641,"activeCount":99},[],{"trials":2643,"activeCount":99},[],{"trials":2645,"activeCount":99},[],{"trials":2647,"activeCount":99},[],{"trials":2649,"activeCount":99},[],{"trials":2651,"activeCount":99},[2652],{"nctId":2653,"briefTitle":2654,"status":147,"phases":2655,"primaryCompletion":2656,"completion":2657,"start":2658,"enrollment":2659,"conditions":2660,"interventions":2662},"NCT05081765","The Effect of Glucose Level and Diabetes Mellitus on Ctrough of Olaparib",[],"2022-10-15","2022-12-31","2021-09-20",40,[2661],"Ovary Cancer",[2638]]